2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)   Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC   Endorsed by the European Stroke Organisation (ESO)

[1]  G. Breithardt,et al.  Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  S. Yusuf,et al.  Clinical ResearchHeart Rhythm DisorderPrevention of Atrial Fibrillation With Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Meta-Analysis , 2005 .

[3]  Y. Woo,et al.  Early surgical intervention or watchful waiting for the management of asymptomatic mitral regurgitation: a systematic review and meta-analysis. , 2015, Annals of cardiothoracic surgery.

[4]  C. Pepine.  Effects of Pharmacologic Therapy on Health-Related Quality of Life in Elderly Patients with Atrial Fibrillation: A Systematic Review of Randomized and Nonrandomized Trials , 2013, Clinical Medicine Insights. Cardiology.

[5]  R. Thomson,et al.  Shared Decision Making: A Model for Clinical Practice , 2012, Journal of General Internal Medicine.

[6]  J. R. Sneyd,et al.  Safe sedation in modern cardiological practice , 2015, Heart.

[7]  D. Singer,et al.  Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. , 2014, American heart journal.

[8]  A. Baranchuk,et al.  Sleep Apnea and Atrial Fibrillation; 2012 Update , 2012, Current cardiology reviews.

[9]  C. Tondo,et al.  Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy , 2009, Journal of cardiovascular electrophysiology.

[10]  P. Sanders,et al.  Effect of dietary fish oil on atrial fibrillation after cardiac surgery. , 2011, The American journal of cardiology.

[11]  D. Singer,et al.  Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation: The Atrial Fibrillation Investigators , 2009, Stroke.

[12]  Michael A. E. Schneider,et al.  Acute and long-term results of radiofrequency ablation of common atrial flutter and the influence of the right atrial isthmus ablation on the occurrence of atrial fibrillation , 2003 .

[13]  V. Hasselblad,et al.  Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. , 2015, The New England journal of medicine.

[14]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[15]  P. Kirchhof,et al.  Left Atrial Catheter Ablation and Ischemic Stroke , 2012, Stroke.

[16]  G. Breithardt,et al.  Impact of Complete Versus Incomplete Circumferential Lines Around the Pulmonary Veins During Catheter Ablation of Paroxysmal Atrial Fibrillation: Results From the Gap-Atrial Fibrillation–German Atrial Fibrillation Competence Network 1 Trial , 2016, Circulation. Arrhythmia and electrophysiology.

[17]  L. Køber,et al.  Stroke and bleeding in atrial fibrillation with chronic kidney disease. , 2012, The New England journal of medicine.

[18]  N. Samani,et al.  Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. , 2005, JAMA.

[19]  A. Ahlsson,et al.  Postoperative atrial fibrillation is not correlated to C-reactive protein. , 2007, The Annals of thoracic surgery.

[20]  D. R. Belgaid.  Ablation vs. amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device , 2016 .

[21]  J. Brachmann,et al.  Relevanz der Magnetresonanztomographie für die Katheterablation von Vorhofflimmern , 2014, Herzschrittmachertherapie + Elektrophysiologie.

[22]  A. Gillinov,et al.  Mitral Regurgitation Associated with Mitral Annular Dilation in Patients with Lone Atrial Fibrillation: An Echocardiographic Study , 2009, Echocardiography.

[23]  Ò. Miró,et al.  Sedation for cardioversion in the emergency department: analysis of effectiveness in four protocols. , 2003, Annals of emergency medicine.

[24]  J. Puskas,et al.  Surgical Ablation for Atrial Fibrillation in Cardiac Surgery a Consensus Statement of the International Society of Minimally Invasive Cardiothoracic Surgery (ISMICS) 2009 , 2010, Innovations.

[25]  J. Hartikainen,et al.  Time to cardioversion for acute atrial fibrillation and thromboembolic complications. , 2014, JAMA.

[26]  A. Camm,et al.  Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation. , 2014, European heart journal.

[27]  Ulrich Schotten,et al.  PITX2c Is Expressed in the Adult Left Atrium, and Reducing Pitx2c Expression Promotes Atrial Fibrillation Inducibility and Complex Changes in Gene Expression , 2011, Circulation. Cardiovascular genetics.

[28]  R. Dickson,et al.  Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy. , 2010, Health technology assessment.

[29]  B. Brembilla-Perrot,et al.  Risk of Atrial Fibrillation After Atrial Flutter Ablation: Impact of AF History, Gender, and Antiarrhythmic Drug Medication , 2014, Journal of cardiovascular electrophysiology.

[30]  G. Breithardt,et al.  Brugada Syndrome and Supraventricular Tachyarrhythmias: A Novel Association? , 2001, Journal of cardiovascular electrophysiology.

[31]  H. Tomoda.  Perioperative Rosuvastatin in Cardiac Surgery. , 2016, The New England journal of medicine.

[32]  Jason C. Fish,et al.  Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[33]  M. Reynolds,et al.  Health Outcomes With Catheter Ablation or Antiarrhythmic Drug Therapy in Atrial Fibrillation: Results of a Propensity-Matched Analysis , 2012, Circulation. Cardiovascular quality and outcomes.

[34]  L. Køber,et al.  Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[35]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[36]  John K Triedman,et al.  Update on Interventional Electrophysiology in Congenital Heart Disease: Evolving Solutions for Complex Hearts , 2013, Circulation. Arrhythmia and electrophysiology.

[37]  M. Frenneaux,et al.  Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. , 1990, Journal of the American College of Cardiology.

[38]  U. Elkayam.  Calcium channel blockers in heart failure. , 1993, Cardiology.

[39]  A. Tveit,et al.  Calcium channel blockers improve exercise capacity and reduce N-terminal Pro-B-type natriuretic peptide levels compared with beta-blockers in patients with permanent atrial fibrillation. , 2014, European heart journal.

[40]  R. Erbel,et al.  Transoesophageal echocardiography for immediate and safe cardioversion in patients with atrial fibrillation. , 2001, European heart journal.

[41]  R. Damiano,et al.  A minimally invasive Cox maze IV procedure is as effective as sternotomy while decreasing major morbidity and hospital stay. , 2014, The Journal of thoracic and cardiovascular surgery.

[42]  Gregory Y H Lip,et al.  Quality of life in patients with atrial fibrillation: a systematic review. , 2006, The American journal of medicine.

[43]  S. Yusuf,et al.  Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies , 2012, Canadian Medical Association Journal.

[44]  R. de Caterina,et al.  Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) , 2013, Thrombosis and Haemostasis.

[45]  S. Mi,et al.  Fish Oil and Atrial Fibrillation after Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials , 2013, PloS one.

[46]  H. Collard,et al.  A practical guide for clinicians who treat patients with amiodarone: 2007. , 2007, Heart rhythm.

[47]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[48]  W. Shimizu,et al.  Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking Dormant Electrical Reconduction by Adenosine TriPhosphate (UNDER-ATP) trial. , 2015, European heart journal.

[49]  L. Friberg,et al.  Benefit of anticoagulation unlikely in patients with atrial fibrillation and a CHA2DS2-VASc score of 1. , 2015, Journal of the American College of Cardiology.

[50]  Salim Yusuf,et al.  Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial , 2010, The Lancet.

[51]  P. Sanders,et al.  A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: a prospective multi-centre randomized controlled trial (the Minimax study). , 2015, European heart journal.

[52]  J. McMurray,et al.  Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study. , 2012, Journal of the American College of Cardiology.

[53]  H. Diener,et al.  Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank , 2001, Stroke.

[54]  J. Plumb,et al.  Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control. , 2009, Thrombosis research.

[55]  G. Lip,et al.  Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study , 2015, Circulation.

[56]  R. Page,et al.  Treatment of arrhythmias during pregnancy. , 1995, American heart journal.

[57]  B. Gersh,et al.  Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study , 2007, Circulation.

[58]  K. Koh,et al.  Efficacy and safety of digoxin alone and in combination with low-dose diltiazem or betaxolol to control ventricular rate in chronic atrial fibrillation. , 1995, The American journal of cardiology.

[59]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[60]  B. Horne,et al.  Warfarin Knowledge in Patients with Atrial Fibrillation: Implications for Safety, Efficacy, and Education Strategies , 2010, Cardiology.

[61]  P. Pernet,et al.  Electrical cardioversion during pregnancy: safe or not? , 2011, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

[62]  M. Mamas,et al.  A meta‐analysis of the prognostic significance of atrial fibrillation in chronic heart failure , 2009, European journal of heart failure.

[63]  G. Lip,et al.  Bleeding During Treatment With Aspirin Versus Apixaban in Patients With Atrial Fibrillation Unsuitable for Warfarin: The Apixaban Versus Acetylsalicylic Acid to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin k Antagonist Treatment (AVERROES) Trial , 2012, Stroke.

[64]  R Brian Haynes,et al.  Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial , 1999, The Lancet.

[65]  B. Lindsay,et al.  Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. , 1996, Journal of the American College of Cardiology.

[66]  K. Okumura,et al.  Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study. , 2006, Circulation journal : official journal of the Japanese Circulation Society.

[67]  V. Somers,et al.  Atrial fibrillation and obesity--results of a meta-analysis. , 2008, American heart journal.

[68]  M. Chung,et al.  Catheter Ablation for Atrial Fibrillation in Heart Failure Patients: A Meta-Analysis of Randomized Controlled Trials. , 2015, JACC. Clinical electrophysiology.

[69]  E. Topol,et al.  Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. , 2014, The American journal of medicine.

[70]  G. Lip,et al.  Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis. , 2008, Journal of the American College of Cardiology.

[71]  Helmut Baumgartner,et al.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). , 2010, European heart journal.

[72]  G. Innes,et al.  Emergency department management and 1-year outcomes of patients with atrial flutter. , 2011, Annals of emergency medicine.

[73]  S. Nattel,et al.  Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. , 2013, Journal of the American College of Cardiology.

[74]  F. Gaita,et al.  Incidence of Silent Cerebral Thromboembolic Lesions After Atrial Fibrillation Ablation May Change According to Technology Used: Comparison of Irrigated Radiofrequency, Multipolar Nonirrigated Catheter and Cryoballoon , 2011, Journal of cardiovascular electrophysiology.

[75]  R. Pini,et al.  Clinical management of atrial fibrillation: early interventions, observation, and structured follow-up reduce hospitalizations. , 2012, The American journal of emergency medicine.

[76]  Marco Proietti,et al.  Asymptomatic versus symptomatic atrial fibrillation: A systematic review of age/gender differences and cardiovascular outcomes. , 2015, International journal of cardiology.

[77]  E. Prescott,et al.  Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study , 2003, European Respiratory Journal.

[78]  T. Roskams,et al.  Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. , 2005, Cardiovascular research.

[79]  J. Bourke,et al.  Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials , 2014, Heart.

[80]  Ralph B D'Agostino,et al.  Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. , 2004, JAMA.

[81]  John Spertus,et al.  Development and Validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in Patients With Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[82]  J. Brugada,et al.  Atrial Fibrillation Catheter Ablation Versus Surgical Ablation Treatment (FAST): A 2-Center Randomized Clinical Trial , 2012, Circulation.

[83]  W. Zareba,et al.  Effect of combined spironolactone-β-blocker ± enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study). , 2010, The American journal of cardiology.

[84]  F. Bourier,et al.  Comparison of safety of left atrial catheter ablation procedures for atrial arrhythmias under continuous anticoagulation with apixaban versus phenprocoumon. , 2015, The American journal of cardiology.

[85]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[86]  J. Hibbard,et al.  What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. , 2013, Health affairs.

[87]  S. Hohnloser,et al.  Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation , 2015, European heart journal.

[88]  M. Crowther.  Antidotes for novel oral anticoagulants: current status and future potential. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[89]  Na Li,et al.  Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation , 2014, Circulation.

[90]  I. V. Van Gelder,et al.  Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation Registry , 2014, Circulation.

[91]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[92]  A. Renzulli,et al.  Impact of lesion sets on mid-term results of surgical ablation procedure for atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[93]  A. Camm,et al.  Vernakalant Hydrochloride for Rapid Conversion of Atrial Fibrillation: A Phase 3, Randomized, Placebo-Controlled Trial , 2008, Circulation.

[94]  Patrick Levy,et al.  Adaptive Servo-Ventilation for Central Sleep Apnea in Systolic Heart Failure. , 2015, The New England journal of medicine.

[95]  Cynthia A. Carnes,et al.  C-Reactive Protein Elevation in Patients With Atrial Arrhythmias: Inflammatory Mechanisms and Persistence of Atrial Fibrillation , 2001, Circulation.

[96]  J. Healey,et al.  Perioperative atrial fibrillation and the long-term risk of ischemic stroke. , 2014, JAMA.

[97]  J. McMurray,et al.  Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK , 2004, Heart.

[98]  J. Brachmann,et al.  [Relevance of magnetic resonance imaging for catheter ablation of atrial fibrillation]. , 2014, Herzschrittmachertherapie & Elektrophysiologie.

[99]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[100]  Dhanunjaya R. Lakkireddy,et al.  Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial , 2016, Circulation.

[101]  J. Nielsen,et al.  Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[102]  Dan M Roden,et al.  Genetic determinants of response to warfarin during initial anticoagulation. , 2008, The New England journal of medicine.

[103]  R. de Caterina,et al.  Major bleeding in patients with atrial fibrillation receiving apixaban or warfarin: The ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation): Predictors, Characteristics, and Clinical Outcomes. , 2014, Journal of the American College of Cardiology.

[104]  A. Natalizi,et al.  Cardioversion of acute atrial fibrillation in the emergency department: a prospective randomised trial , 2011, Emergency Medicine Journal.

[105]  P. Zhang,et al.  Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation * , 2005, International journal of clinical practice.

[106]  L. Fauchier,et al.  Prognostic value of CHA2DS2-VASc score in patients with 'non-valvular atrial fibrillation' and valvular heart disease: the Loire Valley Atrial Fibrillation Project. , 2015, European heart journal.

[107]  S. Mohiuddin,et al.  Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation. , 2006, American heart journal.

[108]  L. Rasmussen,et al.  Risk of Stroke or Systemic Embolism in Atrial Fibrillation Patients Treated With Warfarin: A Systematic Review and Meta-analysis , 2013, Stroke.

[109]  J. Svendsen,et al.  Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial). , 2014, European heart journal.

[110]  B. Maron,et al.  Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy. , 2005, Journal of the American College of Cardiology.

[111]  B. Gersh,et al.  Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) , 2015, Circulation. Cardiovascular quality and outcomes.

[112]  Niels Voigt,et al.  Tachycardia-induced silencing of subcellular Ca2+ signaling in atrial myocytes. , 2014, The Journal of clinical investigation.

[113]  Mkaya Mwamburi,et al.  Systematic Review and Meta-analysis of the Efficacy of Cardioversion by Vernakalant and Comparators in Patients with Atrial Fibrillation , 2012, Cardiovascular Drugs and Therapy.

[114]  B. Hug,et al.  Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomised trial , 2015, The Lancet.

[115]  F. Marchlinski,et al.  Meta-analysis of gender differences in residual stroke risk and major bleeding in patients with nonvalvular atrial fibrillation treated with oral anticoagulants. , 2014, The American journal of cardiology.

[116]  K. Gin,et al.  Oral propafenone for rapid conversion of recent onset atrial fibrillation--a review. , 1997, The Canadian journal of cardiology.

[117]  W. Williams,et al.  Risk factors for atrial tachyarrhythmias after the Fontan operation. , 1994, Journal of the American College of Cardiology.

[118]  M. Weir,et al.  The Cardiac Arrhythmia Suppression Trial Investigators: Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression After Myocardial Infarction. , 1990 .

[119]  Prognostic significance of atrial fibrillation and severity of symptoms of heart failure in patients with low gradient aortic stenosis and preserved left ventricular ejection fraction. , 2014, The American journal of cardiology.

[120]  M. Turakhia,et al.  Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. , 2014, Journal of the American College of Cardiology.

[121]  H. Diener,et al.  Anti-thrombotic therapy in patients with atrial fibrillation and intracranial hemorrhage , 2014, Expert review of neurotherapeutics.

[122]  Jean-Marc Vesin,et al.  Systematic comparison of non-invasive measures for the assessment of atrial fibrillation complexity: a step forward towards standardization of atrial fibrillation electrogram analysis. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[123]  Jagmeet P. Singh,et al.  Atrioventricular nodal ablation in atrial fibrillation: a meta‐analysis of biventricular vs. right ventricular pacing mode , 2012, European Journal of Heart Failure.

[124]  J. Ruskin,et al.  Mutations in the long QT gene, KCNQ1, are an uncommon cause of atrial fibrillation , 2004, Heart.

[125]  J. Baker,et al.  Electrical cardioversion of atrial fibrillation or flutter with conscious sedation in the age of cost containment. , 1998, American heart journal.

[126]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[127]  Angelo Auricchio,et al.  What are the costs of heart failure? , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[128]  D. Ngaage,et al.  Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? , 2007, The Annals of thoracic surgery.

[129]  Faisal Rahman,et al.  Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis , 2016, Nature Reviews Cardiology.

[130]  I. Khan,et al.  Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[131]  A. Manolis,et al.  Transvenous Temporary Cardiac Pacing , 2014 .

[132]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[133]  R. Perera,et al.  Anticoagulation Control and Prediction of Adverse Events in Patients With Atrial Fibrillation: A Systematic Review , 2008, Circulation. Cardiovascular quality and outcomes.

[134]  P. Schauerte,et al.  Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[135]  L. Fauchier,et al.  Oral Anticoagulation and the Risk of Stroke or Death in Patients With Atrial Fibrillation and One Additional Stroke Risk Factor: The Loire Valley Atrial Fibrillation Project. , 2016, Chest.

[136]  Gerhard Hindricks,et al.  Left atrial appendage morphology and thromboembolic risk after catheter ablation for atrial fibrillation. , 2014, Heart rhythm.

[137]  C. Mavroudis,et al.  The Role of Concomitant Arrhythmia Surgery in Patients Undergoing Repair of Congenital Heart Disease , 2008, Pacing and clinical electrophysiology : PACE.

[138]  C. Granger,et al.  Biomarkers in atrial fibrillation: a clinical review. , 2013, European heart journal.

[139]  H. Calkins,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.

[140]  Danielle E. Clarkesmith,et al.  Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation. , 2017, The Cochrane database of systematic reviews.

[141]  H. Crijns,et al.  The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study. , 2011, Journal of the American College of Cardiology.

[142]  G. Hindricks,et al.  Complications of Atrial Fibrillation Ablation in a High‐Volume Center in 1,000 Procedures: Still Cause for Concern? , 2009, Journal of cardiovascular electrophysiology.

[143]  S. Yusuf,et al.  Left Atrial Appendage Occlusion Study II (LAAOS II). , 2013, The Canadian journal of cardiology.

[144]  Prashanthan Sanders,et al.  Approaches to catheter ablation for persistent atrial fibrillation. , 2015, The New England journal of medicine.

[145]  U. Elkayam,et al.  The Pharmacokinetics of Antiarrhythmic Agents in Pregnancy and Lactation , 1987, Clinical pharmacokinetics.

[146]  S. Yusuf,et al.  Newly identified events in the RE-LY trial. , 2010, The New England journal of medicine.

[147]  J. Maessen,et al.  Minimally invasive surgical treatment of lone atrial fibrillation: early results of hybrid versus standard minimally invasive approach employing radiofrequency sources. , 2013, International journal of cardiology.

[148]  S. Gandhi.  Atrial arrhythmia surgery in congenital heart disease , 2007, Journal of Interventional Cardiac Electrophysiology.

[149]  Frank Beckers,et al.  Cryptogenic stroke and underlying atrial fibrillation. , 2014, The New England journal of medicine.

[150]  H. Boyd,et al.  Familial aggregation of lone atrial fibrillation in young persons. , 2012, Journal of the American College of Cardiology.

[151]  Habib Gamra,et al.  Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice: Insight From the Real-Life Global Survey Evaluating Patients With Atrial Fibrillation International Registry , 2012, Circulation. Arrhythmia and electrophysiology.

[152]  H. Wellens.  Contemporary Management of Atrial Flutter , 2002, Circulation.

[153]  P. Sanders,et al.  Epicardial adipose tissue and atrial fibrillation. , 2014, Cardiovascular research.

[154]  Christopher Piorkowski,et al.  Perception of Atrial Fibrillation Before and After Radiofrequency Catheter Ablation: Relevance of Asymptomatic Arrhythmia Recurrence , 2005, Circulation.

[155]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[156]  Dhanunjaya R. Lakkireddy,et al.  Feasibility and safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. , 2012, Journal of the American College of Cardiology.

[157]  D. Roden,et al.  Relation of morbid obesity and female gender to risk of procedural complications in patients undergoing atrial fibrillation ablation. , 2013, The American journal of cardiology.

[158]  A. Wilde,et al.  Expanding Spectrum of Human RYR2-Related Disease: New Electrocardiographic, Structural, and Genetic Features , 2007, Circulation.

[159]  Joshua N. Baker,et al.  Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement. , 2015, The American journal of cardiology.

[160]  Mandeep Bhargava,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. , 2005, JAMA.

[161]  S. Borzak,et al.  A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. , 1998, American heart journal.

[162]  Douglas S. Lee,et al.  Reinitiation of anticoagulation after warfarin-associated intracranial hemorrhage and mortality risk: the Best Practice for Reinitiating Anticoagulation Therapy After Intracranial Bleeding (BRAIN) study. , 2012, The Canadian journal of cardiology.

[163]  S. Themistoclakis,et al.  Efficacy of catheter ablation of atrial fibrillation in patients with hypertrophic obstructive cardiomyopathy. , 2006, Heart rhythm.

[164]  S. Hosoda,et al.  Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. , 2005, European heart journal.

[165]  Luigi Tavazzi,et al.  Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry. , 2015, The American journal of medicine.

[166]  M. Rienstra,et al.  An Update on the Prognosis of Patients With Atrial Fibrillation , 2012, Circulation.

[167]  J. Nerbonne,et al.  Atrial L-type Ca2+ currents and human atrial fibrillation. , 1999, Circulation research.

[168]  J. Hartikainen,et al.  Thromboembolic complications after cardioversion of acute atrial fibrillation: the FinCV (Finnish CardioVersion) study. , 2013, Journal of the American College of Cardiology.

[169]  Bernard J. Gersh,et al.  Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). , 2014, American heart journal.

[170]  C. Morillo,et al.  Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. , 2013, JAMA internal medicine.

[171]  L. Søndergaard,et al.  Anticoagulation in adults with congenital heart disease: The who, the when and the how? , 2014, Heart.

[172]  S. Themistoclakis,et al.  The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. , 2010, Journal of the American College of Cardiology.

[173]  Nick Freemantle,et al.  Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[174]  F. Skjøth,et al.  Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study , 2015, Journal of thrombosis and haemostasis : JTH.

[175]  D. Roden,et al.  Exaggerated QT prolongation after cardioversion of atrial fibrillation. , 1999, Journal of the American College of Cardiology.

[176]  D. Mukherjee,et al.  Timing and Route of Amiodarone for Prevention of Postoperative Atrial Fibrillation after Cardiac Surgery: A Network Regression Meta‐analysis , 2013, Pacing and clinical electrophysiology : PACE.

[177]  Eric E. Smith,et al.  Variants conferring risk of atrial fibrillation on chromosome 4q25 , 2007, Nature.

[178]  J. Ector,et al.  Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[179]  M. Banach,et al.  Atrial Fibrillation After Isolated Coronary Surgery Affects Late Survival , 2008, Circulation.

[180]  J. Cornuz,et al.  Risk of falls and major bleeds in patients on oral anticoagulation therapy. , 2012, The American journal of medicine.

[181]  A. L. Waldo.  Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure , 2009 .

[182]  J. McMurray,et al.  Effects of atenolol, verapamil, and xamoterol on heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation. , 1989, Journal of cardiovascular pharmacology.

[183]  B. Lewis,et al.  Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial , 2012, The Lancet Neurology.

[184]  A. Camm,et al.  European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[185]  K. Koh,et al.  Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study. , 1995, International journal of cardiology.

[186]  D. Singer,et al.  Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. , 2013, The American journal of cardiology.

[187]  S. Nattel,et al.  Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. , 1991, Circulation.

[188]  Bertram Pitt,et al.  Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction , 1996, The Lancet.

[189]  Claes Held,et al.  The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation , 2016, European heart journal.

[190]  W. Budts,et al.  The importance of pulmonary artery pressures and age at repair on late atrial arrhythmia in transcatheter and surgically closed ASD type secundum , 2010 .

[191]  Alastair Baker,et al.  Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.

[192]  G. Paolisso,et al.  Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. , 2015, Journal of diabetes and its complications.

[193]  I. Barbash,et al.  Predictors and clinical implications of atrial fibrillation in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation , 2015, Catheterization and cardiovascular interventions.

[194]  L. Køber,et al.  Efficacy of Dofetilide in the Treatment of Atrial Fibrillation-Flutter in Patients With Reduced Left Ventricular Function: A Danish Investigations of Arrhythmia and Mortality ON Dofetilide (DIAMOND) Substudy , 2001, Circulation.

[195]  A. Zanchetti,et al.  Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial , 2008, Journal of hypertension.

[196]  S. Yusuf,et al.  Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis , 2013, Circulation.

[197]  E. Edelman,et al.  Dabigatran and Rivaroxaban Use in Atrial Fibrillation Patients on Hemodialysis , 2015, Circulation.

[198]  G. Lip,et al.  Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management—a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology , 2015, European heart journal.

[199]  D. Arnar,et al.  Does treatment with n-3 polyunsaturated fatty acids prevent atrial fibrillation after open heart surgery? , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[200]  K. Lorig,et al.  Self-management education: History, definition, outcomes, and mechanisms , 2003, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[201]  S. Yusuf,et al.  Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial , 2011, Circulation.

[202]  Z. Goldberger,et al.  Digitalis use in contemporary clinical practice: refitting the foxglove. , 2014, JAMA internal medicine.

[203]  F. Sacher,et al.  Incidence and Prevention of Cardiac Tamponade Complicating Ablation for Atrial Fibrillation , 2005, Pacing and clinical electrophysiology : PACE.

[204]  S. Koul,et al.  Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome. , 2015, Thrombosis research.

[205]  Simon Stewart,et al.  Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. , 2013, International journal of cardiology.

[206]  A. Tveit,et al.  Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. , 2007, The American journal of cardiology.

[207]  Panagiotis Korantzopoulos,et al.  A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement. , 2013, Journal of the American College of Cardiology.

[208]  I. V. Van Gelder,et al.  Surgical vs. transcatheter pulmonary vein isolation as first invasive treatment in patients with atrial fibrillation: a matched group comparison. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[209]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[210]  S. Chugh,et al.  Meta-analysis of obstructive sleep apnea as predictor of atrial fibrillation recurrence after catheter ablation. , 2011, The American journal of cardiology.

[211]  D. Veenstra,et al.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[212]  P. Kirchhof,et al.  Differences among western European countries in anticoagulation management of atrial fibrillation , 2014, Thrombosis and Haemostasis.

[213]  Bruce M Psaty,et al.  Inflammation as a Risk Factor for Atrial Fibrillation , 2003, Circulation.

[214]  P. Vardas,et al.  Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation. , 2008, Journal of the American College of Cardiology.

[215]  Bertil Olsson,et al.  Outcome parameters for trials in atrial fibrillation: executive summary. , 2007, European heart journal.

[216]  H. Wellens,et al.  Predictive factors of sustained sinus rhythm and recurrent atrial fibrillation after a radiofrequency modified Maze procedure. , 2008, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[217]  J. Cleland,et al.  Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? , 2003, Journal of the American College of Cardiology.

[218]  F A Mathewson,et al.  The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. , 1995, The American journal of medicine.

[219]  P. Kirchhof,et al.  The continuum of personalized cardiovascular medicine: a position paper of the European Society of Cardiology , 2014, European heart journal.

[220]  R. Hall,et al.  Atrial Fibrillation or Flutter During Pregnancy in Patients With Structural Heart Disease: Data From the ROPAC (Registry on Pregnancy and Cardiac Disease). , 2015, JACC. Clinical electrophysiology.

[221]  M. Rich,et al.  Clinical classification schemes for predicting hemorrhage: results from the National Registry of Atrial Fibrillation (NRAF). , 2006, American heart journal.

[222]  L. Ling,et al.  Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. , 2012, Journal of the American College of Cardiology.

[223]  L. Chen,et al.  Physical Activity, Obesity, Weight Change, and Risk of Atrial Fibrillation: The Atherosclerosis Risk in Communities Study , 2014, Circulation. Arrhythmia and electrophysiology.

[224]  K. Filipiak,et al.  Occurrence of poor sleep quality in atrial fi brillation patients according to the EHRA score , 2014, Acta cardiologica.

[225]  Jonathan W. Waks,et al.  Effect of ranolazine on atrial fibrillation in patients with non-ST elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[226]  S. Hunt,et al.  Do we increase the operative risk by adding the Cox Maze III procedure to aortic valve replacement and coronary artery bypass surgery? , 2012, The Journal of thoracic and cardiovascular surgery.

[227]  M. Mack,et al.  Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac Surgery. , 2016, The New England journal of medicine.

[228]  C. Schmitt,et al.  Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation , 2015, Circulation.

[229]  G. Lip,et al.  Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding). , 2013, The American journal of cardiology.

[230]  W. Shen,et al.  Effect of pacing method on risk of sudden death after atrioventricular node ablation and pacemaker implantation in patients with atrial fibrillation. , 2013, Heart rhythm.

[231]  C. Held,et al.  Risk of arrhythmias in 52 755 long-distance cross-country skiers: a cohort study. , 2013, European heart journal.

[232]  E. Lonn,et al.  Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. , 2005, American heart journal.

[233]  Matthew R. Reynolds,et al.  Treatment of Atrial Fibrillation With Antiarrhythmic Drugs or Radiofrequency Ablation: Two Systematic Literature Reviews and Meta-Analyses , 2009, Circulation. Arrhythmia and electrophysiology.

[234]  R. Stroobandt,et al.  Propafenone for conversion and prophylaxis of atrial fibrillation. Propafenone Atrial Fibrillation Trial Investigators. , 1997, The American journal of cardiology.

[235]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[236]  U Schotten,et al.  Cellular Mechanisms of Depressed Atrial Contractility in Patients With Chronic Atrial Fibrillation , 2001, Circulation.

[237]  I. Khan.  Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[238]  G. Lip,et al.  Ethnic Differences in Patient Perceptions of Atrial Fibrillation and Anticoagulation Therapy: The West Birmingham Atrial Fibrillation Project , 2001, Stroke.

[239]  M. Lamberts,et al.  Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study. , 2014, Journal of the American College of Cardiology.

[240]  M. Earing,et al.  Atrial tachyarrhythmias and the Cox-maze procedure in congenital heart disease. , 2013, Congenital heart disease.

[241]  M. Böhm,et al.  Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition , 2010 .

[242]  G. Breithardt,et al.  Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[243]  S. Rimoldi,et al.  Gender Differences in Patients Referred for Atrial Fibrillation Management to a Tertiary Center , 2009, Pacing and clinical electrophysiology : PACE.

[244]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[245]  S. Stock,et al.  Chronic care model strategies in the United States and Germany deliver patient-centered, high-quality diabetes care. , 2014, Health affairs.

[246]  M. Tonelli,et al.  The association between kidney function and major bleeding in older adults with atrial fibrillation starting warfarin treatment: population based observational study , 2015, BMJ : British Medical Journal.

[247]  B. Gersh,et al.  The Natural History of Lone Atrial Flutter , 2004, Annals of Internal Medicine.

[248]  G. Innes,et al.  Safety and efficiency of calcium channel blockers versus beta-blockers for rate control in patients with atrial fibrillation and no acute underlying medical illness. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[249]  A. Kastrati,et al.  Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation. , 2013, Journal of the American College of Cardiology.

[250]  L. Køber,et al.  Increased short-term risk of thrombo-embolism or death after interruption of warfarin treatment in patients with atrial fibrillation. , 2012, European heart journal.

[251]  P. Neužil,et al.  Percutaneous Left Atrial Appendage Closure for Stroke Prophylaxis in Patients With Atrial Fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients With Atrial Fibrillation) Trial , 2013, Circulation.

[252]  G. Breithardt,et al.  Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[253]  B. Maron,et al.  Impact of Atrial Fibrillation on the Clinical Course of Hypertrophic Cardiomyopathy , 2001, Circulation.

[254]  G. Wells,et al.  Relationship Between Pulmonary Vein Reconnection and Atrial Fibrillation Recurrence: A Systematic Review and Meta-Analysis. , 2016, JACC. Clinical electrophysiology.

[255]  G. Lip,et al.  The impact of smoking on thromboembolism and mortality in patients with incident atrial fibrillation: insights from the Danish Diet, Cancer, and Health study. , 2014, Chest.

[256]  Nick Freemantle,et al.  Effect of Cardiac Resynchronization on the Incidence of Atrial Fibrillation in Patients With Severe Heart Failure , 2006, Circulation.

[257]  J. Kaprio,et al.  Lone atrial fibrillation in vigorously exercising middle aged men: case-control study , 1998, BMJ.

[258]  R. Brandes,et al.  Targeting inflammation and oxidative stress in atrial fibrillation: role of 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibition with statins. , 2014, Antioxidants & redox signaling.

[259]  Changsheng Ma,et al.  Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[260]  H. May,et al.  Atrial fibrillation ablation patients have long-term stroke rates similar to patients without atrial fibrillation regardless of CHADS2 score. , 2013, Heart rhythm.

[261]  Sarah N Hilmer,et al.  Review of epidemiology and management of atrial fibrillation in developing countries. , 2013, International journal of cardiology.

[262]  F. Esmailian,et al.  Atrial Extracellular Matrix Remodeling and the Maintenance of Atrial Fibrillation , 2004, Circulation.

[263]  P. Widimsky,et al.  Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study , 2012, European heart journal.

[264]  J. Le Heuzey,et al.  Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study , 2013, Circulation.

[265]  M. Maruthappu,et al.  What size of left atrium significantly impairs the success of maze surgery for atrial fibrillation? , 2011, Interactive cardiovascular and thoracic surgery.

[266]  S. Yoshifuku,et al.  Impact of atrial fibrillation on tricuspid and mitral annular dilatation and valvular regurgitation. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[267]  G. Hindricks,et al.  Vernakalant-facilitated electrical cardioversion: comparison of intravenous vernakalant and amiodarone for drug-enhanced electrical cardioversion of atrial fibrillation after failed electrical cardioversion , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[268]  Pamela J. McCabe.  Self-management of atrial fibrillation: a new frontier for nursing research. , 2008, Progress in cardiovascular nursing.

[269]  E. Kuhn,et al.  Preoperative statin therapy for patients undergoing cardiac surgery. , 2016, The Cochrane database of systematic reviews.

[270]  L. Henry,et al.  Are There Gender Differences in Outcomes after the Cox-Maze Procedure for Atrial Fibrillation? , 2013, Innovations.

[271]  G. Lip,et al.  Stroke prevention in atrial fibrillation , 2016, The Lancet.

[272]  D. Hodge,et al.  Outcome of direct current cardioversion for atrial arrhythmias in adults with congenital heart disease. , 2012, International journal of cardiology.

[273]  B. Rochwerg,et al.  Endovascular Thrombectomy for Acute Ischemic Stroke: A Meta-analysis. , 2015, JAMA.

[274]  S. Tanaka,et al.  [Studies on atrial arrhythmias in atrial septal defect. The influences of aging on atrial fibrillation]. , 1995, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics.

[275]  Randy L. Johnson,et al.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification , 2010, Proceedings of the National Academy of Sciences.

[276]  G. Breithardt,et al.  Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF , 2012, The Lancet Neurology.

[277]  M. Chiariello,et al.  Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.

[278]  Peng-Sheng Chen,et al.  Histopathological substrate for chronic atrial fibrillation in humans. , 2009, Heart rhythm.

[279]  Jagmeet P. Singh,et al.  Atrioventricular Nodal Ablation in Atrial Fibrillation: A Meta-Analysis and Systematic Review , 2012, Circulation. Arrhythmia and electrophysiology.

[280]  A. Capucci,et al.  Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events , 2014, Circulation.

[281]  W. Abhayaratna,et al.  Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. , 2013, JAMA.

[282]  A. Hosseinpour,et al.  Influence of Atrial Fibrillation on Outcome Following Mitral Valve Repair , 2001, Circulation.

[283]  E. Tuzcu,et al.  Percutaneous left atrial appendage occlusion for stroke prophylaxis in nonvalvular atrial fibrillation: a systematic review and analysis of observational studies. , 2014, JACC. Cardiovascular interventions.

[284]  Hubert Cochet,et al.  Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint , 2015, Circulation. Arrhythmia and electrophysiology.

[285]  P. Sanders,et al.  Effect of atrial fibrillation on atrial thrombogenesis in humans: impact of rate and rhythm. , 2013, Journal of the American College of Cardiology.

[286]  S. Nattel,et al.  Ranolazine: Ion‐channel‐blocking actions and in vivo electrophysiological effects , 2004, British journal of pharmacology.

[287]  U. Schotten,et al.  Lone atrial fibrillation: does it exist? , 2014, Journal of the American College of Cardiology.

[288]  M. Rosenqvist,et al.  Prospective study of left ventricular function after radiofrequency ablation of atrioventricular junction in patients with atrial fibrillation. , 1995, British heart journal.

[289]  S. Majidi,et al.  The effect of atrial fibrillation on outcomes in patients undergoing carotid endarterectomy or stent placement in general practice. , 2015, Journal of vascular surgery.

[290]  D. Wyse,et al.  Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. , 2002, Journal of the American College of Cardiology.

[291]  G. Lip,et al.  Prior history of falls and risk of outcomes in atrial fibrillation: the Loire Valley Atrial Fibrillation Project. , 2014, The American journal of medicine.

[292]  R. Pai,et al.  A Multidisciplinary Atrial Fibrillation Clinic , 2013, Current cardiology reviews.

[293]  J. Burkhardt,et al.  Impact of Rotor Ablation in Non-Paroxysmal AF Patients: Results from a Randomized Trial (OASIS). , 2016 .

[294]  P. Serruys,et al.  Long-term invasive follow-up of the everolimus-eluting bioresorbable vascular scaffold: five-year results of multiple invasive imaging modalities. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[295]  E. Bernal,et al.  Use of Irbesartan to Maintain Sinus Rhythm in Patients With Long-Lasting Persistent Atrial Fibrillation: A Prospective and Randomized Study , 2002, Circulation.

[296]  I. V. Van Gelder,et al.  Digoxin in patients with permanent atrial fibrillation: data from the RACE II study. , 2014, Heart rhythm.

[297]  S. Connolly,et al.  Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials. , 2006, American heart journal.

[298]  V. Somers,et al.  Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. , 2007, Journal of the American College of Cardiology.

[299]  G. Hindricks,et al.  Effects of Sex on the Incidence of Cardiac Tamponade After Catheter Ablation of Atrial Fibrillation: Results From a Worldwide Survey in 34 943 Atrial Fibrillation Ablation Procedures , 2014, Circulation. Arrhythmia and electrophysiology.

[300]  G. Lip,et al.  Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation: AMADEUS Trial , 2015, Stroke.

[301]  G. Lip,et al.  The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation. , 2013, Journal of the American College of Cardiology.

[302]  A. Salvador,et al.  Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. , 2004, Journal of the American College of Cardiology.

[303]  G. Breithardt,et al.  A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[304]  Jamil Mayet,et al.  A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial) , 2014, Circulation. Arrhythmia and electrophysiology.

[305]  N. Geller,et al.  Surgical ablation of atrial fibrillation during mitral-valve surgery. , 2015, The New England journal of medicine.

[306]  N. Abraham,et al.  Comparative risk of gastrointestinal bleeding with dabigatran, rivaroxaban, and warfarin: population based cohort study , 2015, BMJ : British Medical Journal.

[307]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease. , 2007, European heart journal.

[308]  J. Dimarco,et al.  Management of Atrial Fibrillation in Patients With Structural Heart Disease , 2012, Circulation.

[309]  D. Ferrante,et al.  Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial. , 2013, Journal of the American College of Cardiology.

[310]  G. Boriani,et al.  Device-detected atrial tachyarrhythmias predict adverse outcome in real-world patients with implantable biventricular defibrillators. , 2011, Journal of the American College of Cardiology.

[311]  T. Wieland,et al.  Enhanced Sarcoplasmic Reticulum Ca2+ Leak and Increased Na+-Ca2+ Exchanger Function Underlie Delayed Afterdepolarizations in Patients With Chronic Atrial Fibrillation , 2012, Circulation.

[312]  P. Noseworthy,et al.  Meta-Analysis of Renal Function on the Safety and Efficacy of Novel Oral Anticoagulants for Atrial Fibrillation. , 2016, The American journal of cardiology.

[313]  J. Triedman.  Arrhythmias in adults with congenital heart disease , 2002, Heart.

[314]  A. Ahlsson,et al.  Patients with postoperative atrial fibrillation have a doubled cardiovascular mortality , 2009, Scandinavian cardiovascular journal : SCJ.

[315]  A. Moorman,et al.  A Gain-of-Function TBX5 Mutation Is Associated With Atypical Holt–Oram Syndrome and Paroxysmal Atrial Fibrillation , 2008, Circulation research.

[316]  G. Lip,et al.  Safety and efficacy of well managed warfarin , 2015, Thrombosis and Haemostasis.

[317]  J. Camm,et al.  The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. , 2000, Journal of the American College of Cardiology.

[318]  K. Lunetta,et al.  Integrating Genetic, Transcriptional, and Functional Analyses to Identify 5 Novel Genes for Atrial Fibrillation , 2014, Circulation.

[319]  K. Murray,et al.  Analysis of Cause-Specific Mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study , 2004, Circulation.

[320]  S. Hohnloser,et al.  Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation. Results from a prospective randomized study. , 2003, European heart journal.

[321]  K. Sugi,et al.  Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[322]  Hans L Hillege,et al.  Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands. , 2015, Journal of the American College of Cardiology.

[323]  C. Zou,et al.  Comparative study of video-assisted thoracoscopic surgery ablation and radiofrequency catheter ablation on treating paroxysmal atrial fibrillation: a randomized, controlled short-term trial. , 2014, Chinese medical journal.

[324]  Tommy Andersson,et al.  All-cause mortality in 272 186 patients hospitalized with incident atrial fibrillation 1995–2008: a Swedish nationwide long-term case–control study , 2013, European heart journal.

[325]  D. Delurgio,et al.  New-onset atrial fibrillation predicts long-term mortality after coronary artery bypass graft. , 2010, Journal of the American College of Cardiology.

[326]  F. Morady,et al.  Body Mass Index, Obstructive Sleep Apnea, and Outcomes of Catheter Ablation of Atrial Fibrillation , 2008, Journal of cardiovascular electrophysiology.

[327]  W. Lehmacher,et al.  Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial , 2004, Circulation.

[328]  G. Lip,et al.  Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study , 2015, Stroke.

[329]  K. Olesen.  THE NATURAL HISTORY OF 271 PATIENTS WITH MITRAL STENOSIS UNDER MEDICAL TREATMENT , 1962, British heart journal.

[330]  H. Diener,et al.  Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2012, Stroke.

[331]  Matthew J. Crowley,et al.  Rate- and Rhythm-Control Therapies in Patients With Atrial Fibrillation , 2014, Annals of Internal Medicine.

[332]  Stephan Willems,et al.  Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial , 2015, The Lancet.

[333]  S. Jensen,et al.  A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). , 2007, European heart journal.

[334]  Martha J. Radford,et al.  Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation , 2001 .

[335]  C. Good,et al.  Amiodarone to prevent recurrence of atrial fibrillation. , 2000, The New England journal of medicine.

[336]  W. Daniel,et al.  Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial. , 2007, Thrombosis Research.

[337]  M. Pfeffer,et al.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, Journal of the American College of Cardiology.

[338]  P. Kirchhof,et al.  Rate and rhythm control have comparable effects on mortality and stroke in atrial fibrillation but better data are needed , 2014, Evidence-Based Medicine.

[339]  A. Speir,et al.  Postoperative atrial fibrillation significantly increases mortality, hospital readmission, and hospital costs. , 2014, The Annals of thoracic surgery.

[340]  M. Mansour,et al.  Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. , 2014, Journal of the American College of Cardiology.

[341]  L. Wallentin,et al.  New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis , 2013, European heart journal.

[342]  M. Castellà,et al.  Thoracoscopic pulmonary vein isolation in patients with atrial fibrillation and failed percutaneous ablation. , 2010, The Journal of thoracic and cardiovascular surgery.

[343]  F. Gaita,et al.  Long-term events following atrial fibrillation rate control or transcatheter ablation: a multicenter observational study , 2016, Journal of cardiovascular medicine.

[344]  J. Healey,et al.  Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. , 2014, Annals of cardiothoracic surgery.

[345]  M. Haumer,et al.  Amiodarone versus diltiazem for rate control in critically ill patients with atrial tachyarrhythmias , 2001, Critical care medicine.

[346]  J. Brugada,et al.  Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG , 2003, Circulation.

[347]  F. Pomero,et al.  Reversal strategies for vitamin K antagonists in acute intracerebral hemorrhage , 2015, Annals of neurology.

[348]  G. Breithardt,et al.  Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options , 2011, Thrombosis and Haemostasis.

[349]  P. Kirchhof,et al.  Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis , 2016, British Medical Journal.

[350]  Martin O'Donnell,et al.  Apixaban versus aspirin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a predefined subgroup analysis from AVERROES, a randomised trial , 2012, The Lancet Neurology.

[351]  G. Breithardt,et al.  Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial Running title: Goette et al.; The ANTIPAF Trial , 2010 .

[352]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[353]  N. G. Silveri,et al.  Efficacy and Safety of Vernakalant in Recent‐Onset Atrial Fibrillation After the European Medicines Agency Approval: Systematic Review and Meta‐Analysis , 2012, Journal of clinical pharmacology.

[354]  A. Capucci,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[355]  Mårten Rosenqvist,et al.  Stepwise Screening of Atrial Fibrillation in a 75-Year-Old Population: Implications for Stroke Prevention , 2013, Circulation.

[356]  S. Lotfipour,et al.  Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation , 2010, Internal and emergency medicine.

[357]  R. Blankstein,et al.  The incidence, pattern, and prognostic value of left ventricular myocardial scar by late gadolinium enhancement in patients with atrial fibrillation . , 2013, Journal of the American College of Cardiology.

[358]  M. Aguilar,et al.  Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. , 2007, Annals of internal medicine.

[359]  Hans-ChristophDiener,et al.  Nonvitamin-K-Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack , 2012 .

[360]  P. Macfarlane,et al.  Effect of statins on atrial fibrillation: collaborative meta-analysis of published and unpublished evidence from randomised controlled trials , 2011, BMJ : British Medical Journal.

[361]  I. V. Van Gelder,et al.  The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[362]  J. Halperin,et al.  Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. , 2001, The New England journal of medicine.

[363]  S. Kische,et al.  Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry , 2016, European heart journal.

[364]  I. V. Van Gelder,et al.  Sudden Cardiac Death in Adult Congenital Heart Disease , 1996, Circulation.

[365]  L. Sposato,et al.  Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis. , 2016, Stroke.

[366]  J. Towbin,et al.  Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. , 2013, Journal of the American College of Cardiology.

[367]  D. Roden,et al.  Chromosome 4q25 variants are genetic modifiers of rare ion channel mutations associated with familial atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[368]  S. Kitamura,et al.  Maze procedure for atrial fibrillation associated with atrial septal defect. , 1998, Circulation.

[369]  A. Gillis,et al.  Temporal patterns of paroxysmal atrial fibrillation following DDDR pacemaker implantation. , 2000, The American journal of cardiology.

[370]  Otto Kamp,et al.  Lenient versus strict rate control in patients with atrial fibrillation. , 2010, The New England journal of medicine.

[371]  J. Maessen,et al.  Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[372]  S. Nattel,et al.  Dynamic Nature of Atrial Fibrillation Substrate During Development and Reversal of Heart Failure in Dogs , 2002, Circulation.

[373]  T. McDonagh,et al.  Heart Failure Epidemiology: European Perspective , 2013, Current cardiology reviews.

[374]  J. Beyer-Westendorf,et al.  Rates, management, and outcome of rivaroxaban bleeding in daily care: results from the Dresden NOAC registry. , 2014, Blood.

[375]  G. Agnelli,et al.  Should oral anticoagulants be restarted after warfarin-associated cerebral haemorrhage in patients with atrial fibrillation? , 2013, Thrombosis and Haemostasis.

[376]  D. Ferrante,et al.  N‐3 Polyunsaturated Fatty Acids to Prevent Atrial Fibrillation: Updated Systematic Review and Meta‐Analysis of Randomized Controlled Trials , 2013, Journal of the American Heart Association.

[377]  Jacob P. Kelly,et al.  Patient selection in heart failure with preserved ejection fraction clinical trials. , 2015, Journal of the American College of Cardiology.

[378]  D. Roden,et al.  Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion. , 2013, Heart rhythm.

[379]  S. Connolly,et al.  Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity. , 2015, The New England journal of medicine.

[380]  C. Gstrein,et al.  Optimization of initial energy for cardioversion of atrial tachyarrhythmias with biphasic shocks. , 2010, The American journal of emergency medicine.

[381]  Mark Levenson,et al.  Cardiovascular, Bleeding, and Mortality Risks in Elderly Medicare Patients Treated With Dabigatran or Warfarin for Nonvalvular Atrial Fibrillation , 2015, Circulation.

[382]  Rafael A. Peinado,et al.  Diferencias en la calidad de vida según el tipo de fibrilación auricular , 2010 .

[383]  A. Venturi,et al.  Cardioversion of acute atrial fibrillation in the short observation unit: comparison of a protocol focused on electrical cardioversion with simple antiarrhythmic treatment , 2010, Emergency Medicine Journal.

[384]  G. Breithardt,et al.  Valvular heart disease among non-valvular atrial fibrillation: a misnomer, in search of a new term. , 2015, European heart journal.

[385]  R. Hunter,et al.  Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death , 2011, Heart.

[386]  W. Lehmacher,et al.  Economic Evaluation of Enoxaparin for Anticoagulation in Early Cardioversion of Persisting Nonvalvular Atrial Fibrillation , 2007, American journal of cardiovascular drugs : drugs, devices, and other interventions.

[387]  B. Maron,et al.  Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population , 1998, Heart.

[388]  E. Hoffmann,et al.  Comparison of the First and Second Cryoballoon: High-Volume Single-Center Safety and Efficacy Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[389]  G. Lip,et al.  The impact of associated diabetic retinopathy on stroke and severe bleeding risk in diabetic patients with atrial fibrillation: the loire valley atrial fibrillation project. , 2015, Chest.

[390]  R. Vierkant,et al.  Incidence and predictors of atrial flutter in the general population. , 2000, Journal of the American College of Cardiology.

[391]  Michel Haissaguerre,et al.  Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[392]  P. Kirchhof,et al.  Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. , 2011, Physiological reviews.

[393]  C. Albert,et al.  Type 2 diabetes mellitus and risk of incident atrial fibrillation in women. , 2012, Journal of the American College of Cardiology.

[394]  R. Verlato,et al.  Long term follow up of radiofrequency catheter ablation of atrial flutter: clinical course and predictors of atrial fibrillation occurrence , 2003, Heart.

[395]  A. Skanes,et al.  When should we recommend catheter ablation for patients with the Wolff–Parkinson–White syndrome? , 2008, Current opinion in cardiology.

[396]  G. Breithardt,et al.  Short-term versus long-term antiarrhythmic drug treatment after cardioversion of atrial fibrillation (Flec-SL): a prospective, randomised, open-label, blinded endpoint assessment trial , 2012, The Lancet.

[397]  G. Kay,et al.  Clinical outcomes after ablation and pacing therapy for atrial fibrillation : a meta-analysis. , 2000, Circulation.

[398]  E. Toft,et al.  Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery: A Randomized, Double-Blind, Placebo-Controlled Trial , 2009, Circulation. Arrhythmia and electrophysiology.

[399]  Frank Bogun,et al.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation. , 2006, The New England journal of medicine.

[400]  A. Manolis,et al.  Vernakalant: Review of a Novel Atrial Selective Antiarrhythmic Agent and its Place in Current Treatment of Atrial Fibrillation , 2012 .

[401]  B. McCrindle,et al.  Tachyarrhythmias With Digoxin , Flecainide , and Sotalol : Results of a Comparison of Transplacental Treatment of Fetal Supraventricular , 2011 .

[402]  J. Halperin,et al.  Atrial fibrillation and stroke: new ideas, persisting dilemmas. , 1988, Stroke.

[403]  M. Price,et al.  Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. , 2014, Journal of the American College of Cardiology.

[404]  I. Bryngelsson,et al.  Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. , 2014, International journal of cardiology.

[405]  M. Matsuzaki,et al.  Simultaneous Doppler tracing of transmitral inflow and mitral annular velocity as an estimate of elevated left ventricular filling pressure in patients with atrial fibrillation. , 2012, Circulation journal : official journal of the Japanese Circulation Society.

[406]  A. Gitt,et al.  Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study , 2013, Clinical Research in Cardiology.

[407]  F. Morady,et al.  Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. , 1999, The New England journal of medicine.

[408]  P. Kirchhof,et al.  Atrial fibrillation and heart failure due to reduced versus preserved ejection fraction: A systematic review and meta-analysis of death and adverse outcomes. , 2016, International journal of cardiology.

[409]  H. B. Sprague,et al.  The course of mitral stenosis without surgery: ten- and twenty-year perspectives. , 1960, Annals of internal medicine.

[410]  Lars-Åke Levin,et al.  Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP). , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[411]  G. Lip,et al.  Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis. , 2015, European heart journal.

[412]  Sudha Seshadri,et al.  50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study , 2015, The Lancet.

[413]  G. Breithardt,et al.  Relationship Between Time in Therapeutic Range and Comparative Treatment Effect of Rivaroxaban and Warfarin: Results From the ROCKET AF Trial , 2014, Journal of the American Heart Association.

[414]  B. Monz,et al.  Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[415]  A. Camm,et al.  Vernakalant: conversion of atrial fibrillation in patients with ischemic heart disease. , 2013, International journal of cardiology.

[416]  Laura J. Bonnett,et al.  Efficacy of Catheter Ablation for Persistent Atrial Fibrillation: A Systematic Review and Meta-Analysis of Evidence From Randomized and Nonrandomized Controlled Trials , 2014, Circulation. Arrhythmia and electrophysiology.

[417]  G. Heinze,et al.  Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. , 2004, European heart journal.

[418]  A. Camm,et al.  Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[419]  G. Lip,et al.  Factors Affecting Quality of Anticoagulation Control Among Patients With Atrial Fibrillation on Warfarin The SAMe-TT 2 R 2 Score , 2022 .

[420]  B. Maron,et al.  Patterns of ventricular tachyarrhythmias associated with training, deconditioning and retraining in elite athletes without cardiovascular abnormalities. , 2011, The American journal of cardiology.

[421]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.

[422]  P. Kirchhof,et al.  Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF) , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[423]  T. Nikolaidou,et al.  Chronic atrial fibrillation: a systematic review of medical heart rate control management , 2009, Postgraduate Medical Journal.

[424]  M. Gasparini,et al.  Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion. , 1999, Journal of the American College of Cardiology.

[425]  G. Lip,et al.  Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT₂R₂ score. , 2013, Chest.

[426]  D. Franco,et al.  Modulation of conductive elements by Pitx2 and their impact on atrial arrhythmogenesis. , 2011, Cardiovascular research.

[427]  S. Yusuf,et al.  Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion , 2010, Circulation.

[428]  M. Santini,et al.  n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[429]  A. Sato,et al.  Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. , 2013, Heart rhythm.

[430]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[431]  A. Garson,et al.  Atrial Arrhythmias During Chronic Follow‐Up of Surgery for Complex Congenital Heart Disease , 1997, Pacing and clinical electrophysiology : PACE.

[432]  A. Térent,et al.  Comparison of Cardiovascular Risk Factors and Survival in Patients with Ischemic or Hemorrhagic Stroke , 2012, International journal of stroke : official journal of the International Stroke Society.

[433]  J. Hartikainen,et al.  Arrhythmic complications after electrical cardioversion of acute atrial fibrillation: the FinCV study. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[434]  Burr Hall,et al.  Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[435]  T. Chao,et al.  Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? , 2015, Journal of the American College of Cardiology.

[436]  J. Brugada,et al.  Sport practice and the risk of lone atrial fibrillation: a case-control study. , 2006, International journal of cardiology.

[437]  R. Tieleman,et al.  The atrial fibrillation knowledge scale: development, validation and results. , 2013, International journal of cardiology.

[438]  G. Lip,et al.  Alcohol intake and prognosis of atrial fibrillation , 2013, Heart.

[439]  R. Califf,et al.  Is Rhythm‐Control Superior to Rate‐Control in Patients with Atrial Fibrillation and Diastolic Heart Failure? , 2010, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[440]  Hugh Calkins,et al.  Catheter ablation in patients with persistent atrial fibrillation , 2016, European heart journal.

[441]  Chen Li,et al.  Will simultaneous measurement of E/e' index facilitate the non-invasive assessment of left ventricular filling pressure in patients with non-valvular atrial fibrillation? , 2010, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.

[442]  U. Ravens,et al.  Arrhythmias, elicited by catecholamines and serotonin, vanish in human chronic atrial fibrillation , 2014, Proceedings of the National Academy of Sciences.

[443]  Ping-Yen Liu,et al.  Clinical characteristics and outcomes of hypertrophic cardiomyopathy in Taiwan—a tertiary center experience , 2007, Clinical cardiology.

[444]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[445]  A. Camm,et al.  Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[446]  Hsueh-Wen Chang,et al.  Preoperative atrial size predicts the success of radiofrequency maze procedure for permanent atrial fibrillation in patients undergoing concomitant valvular surgery. , 2004, Chest.

[447]  S. Jafri.  Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy. , 2004, American heart journal.

[448]  A. Gillinov,et al.  Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. , 2005, The Journal of thoracic and cardiovascular surgery.

[449]  M. Hochman.  Rate Control versus Rhythm Control for Atrial Fibrillation , 2013 .

[450]  W. F. Greenwood,et al.  The natural history of mitral stenosis. , 1954, Canadian Medical Association journal.

[451]  Alexander Parkhomenko,et al.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials , 2014, The Lancet.

[452]  W. Fu,et al.  Updated systematic review and meta-analysis of randomized clinical trials comparing carotid artery stenting and carotid endarterectomy in the treatment of carotid stenosis. , 2012, Annals of vascular surgery.

[453]  B. Gorenek,et al.  Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisi , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[454]  André C. Linnenbank,et al.  Thoracoscopic Video-Assisted Pulmonary Vein Antrum Isolation, Ganglionated Plexus Ablation, and Periprocedural Confirmation of Ablation Lesions: First Results of a Hybrid Surgical-Electrophysiological Approach for Atrial Fibrillation , 2011, Circulation. Arrhythmia and electrophysiology.

[455]  G. Lip,et al.  Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis. , 2014, QJM : monthly journal of the Association of Physicians.

[456]  P. Kirchhof,et al.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association , 2014, European heart journal.

[457]  W. V. van Boven,et al.  Completely thoracoscopic bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. , 2008, The Journal of thoracic and cardiovascular surgery.

[458]  Wataru Shimizu,et al.  Executive Summary: HRS/EHRA/APHRS Expert Consensus Statement on the Diagnosis and Management of Patients with Inherited Primary Arrhythmia Syndromes , 2013, Heart rhythm.

[459]  A. Banerjee,et al.  Pattern of atrial fibrillation and risk of outcomes: the Loire Valley Atrial Fibrillation Project. , 2012, International journal of cardiology.

[460]  Y. Ko,et al.  Predictors of Systemic Embolism in Patients with Mitral Stenosis: A Prospective Study , 1998, Annals of Internal Medicine.

[461]  M. Gardner,et al.  An Integrated Management Approach to Atrial Fibrillation , 2016, Journal of the American Heart Association.

[462]  Y. Adler,et al.  Colchicine for prevention of postpericardiotomy syndrome and postoperative atrial fibrillation: the COPPS-2 randomized clinical trial. , 2014, JAMA.

[463]  S. Lévy.  Factors Predisposing to the Development of Atrial Fibrillation , 1997, Pacing and clinical electrophysiology : PACE.

[464]  M. Cooper,et al.  Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial. , 2004, American heart journal.

[465]  R. Corzo,et al.  Mortality and morbidity of heart failure treated with digoxin. A propensity‐matched study , 2011, International journal of clinical practice.

[466]  Saibal Kar,et al.  Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis. , 2015, Journal of the American College of Cardiology.

[467]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[468]  G. Lip,et al.  Body mass index and adverse events in patients with incident atrial fibrillation. , 2013, The American journal of medicine.

[469]  Jeroen J. Bax,et al.  Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[470]  Randall J. Lee,et al.  Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation , 2014, Journal of Interventional Cardiac Electrophysiology.

[471]  A. Camm,et al.  Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[472]  P. Weeke,et al.  Bleeding risk in ‘real world’ patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort , 2011, Journal of thrombosis and haemostasis : JTH.

[473]  A. Natale,et al.  Silent Cerebral Events/Lesions Related to Atrial Fibrillation Ablation: A Clinical Review , 2015, Journal of cardiovascular electrophysiology.

[474]  Christian Weimar,et al.  Improved Detection of Silent Atrial Fibrillation Using 72-Hour Holter ECG in Patients With Ischemic Stroke: A Prospective Multicenter Cohort Study , 2013, Stroke.

[475]  H. Crijns,et al.  Cost-effectiveness of a specialized atrial fibrillation clinic vs. usual care in patients with atrial fibrillation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[476]  Steve Enger,et al.  Comparison of four single-drug regimens on ventricular rate and arrhythmia-related symptoms in patients with permanent atrial fibrillation. , 2013, The American journal of cardiology.

[477]  Sonal Singh,et al.  Risk of gastrointestinal bleeding associated with oral anticoagulants: population based retrospective cohort study , 2015, BMJ : British Medical Journal.

[478]  R. Bai,et al.  Pacing or Ablation: Which Is Better for Paroxysmal Atrial Fibrillation‐Related Tachycardia‐Bradycardia Syndrome? , 2014, Pacing and clinical electrophysiology : PACE.

[479]  Sang Joon Park,et al.  Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation , 1995 .

[480]  A. Skanes,et al.  A novel, simple scale for assessing the symptom severity of atrial fibrillation at the bedside: the CCS-SAF scale. , 2006, The Canadian journal of cardiology.

[481]  Michel Haissaguerre,et al.  Short QT syndrome: clinical findings and diagnostic-therapeutic implications. , 2006, European heart journal.

[482]  Sverker Jern,et al.  Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. , 2006, JAMA.

[483]  A. Kadish,et al.  Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. , 2010, The Journal of thoracic and cardiovascular surgery.

[484]  A. R. Rivera,et al.  Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin. , 1997, Annals of emergency medicine.

[485]  S. Larsson,et al.  Alcohol consumption and risk of atrial fibrillation: a prospective study and dose-response meta-analysis. , 2014, Journal of the American College of Cardiology.

[486]  V. Hasselblad,et al.  Is Cardiac Resynchronization Therapy an Antiarrhythmic Therapy for Atrial Fibrillation? A Systematic Review and Meta-Analysis , 2013, Current Cardiology Reports.

[487]  B. Cosmi,et al.  Bleeding with anticoagulation therapy – Who is at risk, and how best to identify such patients , 2009, Thrombosis and Haemostasis.

[488]  G. Hankey,et al.  Management of acute stroke in patients taking novel oral anticoagulants , 2014, International journal of stroke : official journal of the International Stroke Society.

[489]  K. Coleman,et al.  Integrated care for chronic conditions: the contribution of the ICCC Framework. , 2012, Health policy.

[490]  D. Rinkes,et al.  Validation and clinical use of a novel diagnostic device for screening of atrial fibrillation , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[491]  K. Phan,et al.  Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[492]  A L Waldo,et al.  A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.

[493]  S. Yusuf,et al.  Concomitant Use of Antiplatelet Therapy with Dabigatran or Warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial , 2013, Circulation.

[494]  John Calvin Reed,et al.  Myocardial cell death in fibrillating and dilated human right atria. , 1999, Journal of the American College of Cardiology.

[495]  J. McClelland,et al.  Preliminary Results of a Limited Thoracotomy: New Approach to Treat Atrial Fibrillation , 2007, Journal of cardiovascular electrophysiology.

[496]  A. Malhotra,et al.  Effect of Sleep Apnea and Continuous Positive Airway Pressure on Cardiac Structure and Recurrence of Atrial Fibrillation , 2013, Journal of the American Heart Association.

[497]  H. Crijns,et al.  Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[498]  David O. Martin,et al.  Pulmonary Vein Isolation for Atrial Fibrillation in Patients with Symptomatic Sinus Bradycardia or Pauses , 2004, Journal of cardiovascular electrophysiology.

[499]  P. O’Neill,et al.  Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization. , 2015, Heart rhythm.

[500]  G. Lip,et al.  Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk. , 2011, Journal of the American College of Cardiology.

[501]  R. Berntsen,et al.  Focal impulse and rotor modulation as a stand-alone procedure for the treatment of paroxysmal atrial fibrillation: A within-patient controlled study with implanted cardiac monitoring. , 2016, Heart rhythm.

[502]  W. O’Neill,et al.  Utilization and Adverse Outcomes of Percutaneous Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation in the United States: Influence of Hospital Volume , 2015, Circulation. Arrhythmia and electrophysiology.

[503]  Christopher E Hilker,et al.  Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: a subgroup analysis of TRENDS. , 2011, Heart rhythm.

[504]  E. Benjamin,et al.  Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study). , 2014, American heart journal.

[505]  P. Elliott,et al.  Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review , 2013, Heart.

[506]  I. V. Van Gelder,et al.  Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[507]  A Hofman,et al.  Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. , 1997, Stroke.

[508]  G. Lip,et al.  Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review. , 2007, QJM : monthly journal of the Association of Physicians.

[509]  P. Andersen,et al.  The effectiveness of structured personal care of type 2 diabetes on recurrent outcomes: a 19 year follow-up of the study Diabetes Care in General Practice (DCGP) , 2014, Diabetologia.

[510]  J. Burkhardt,et al.  Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study. , 2015, Heart rhythm.

[511]  Mark D. Huffman,et al.  Concomitant atrial fibrillation surgery for people undergoing cardiac surgery. , 2016, The Cochrane database of systematic reviews.

[512]  G. Breithardt,et al.  Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial , 2014, European heart journal.

[513]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[514]  A. Capucci,et al.  A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[515]  L. Køber,et al.  Oral anticoagulation therapy after radiofrequency ablation of atrial fibrillation and the risk of thromboembolism and serious bleeding: long-term follow-up in nationwide cohort of Denmark. , 2015, European heart journal.

[516]  K. Tanabe,et al.  Dynamic freehand three-dimensional echocardiography : clinical feasible alternative for precise and accurate measurement of left ventricular volumes , 2002 .

[517]  P. Scuffham,et al.  Standard versus atrial fibrillation-specific management strategy (SAFETY) to reduce recurrent admission and prolong survival: pragmatic, multicentre, randomised controlled trial , 2015, The Lancet.

[518]  A. Waldo.  Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for The cOntrol of ventricular rate during atrial fibrillation (ERATO) study , 2009 .

[519]  D. Schwartzman,et al.  Interim results of the 5-box thoracoscopic maze procedure. , 2012, The Annals of thoracic surgery.

[520]  G. Lip,et al.  Balancing stroke and bleeding risks in patients with atrial fibrillation and renal failure: the Swedish Atrial Fibrillation Cohort study. , 2015, European heart journal.

[521]  D. Mozaffarian,et al.  Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial. , 2012, JAMA.

[522]  Laurent Pison,et al.  Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[523]  D. Mozaffarian,et al.  Plasma Phospholipid Omega‐3 Fatty Acids and Incidence of Postoperative Atrial Fibrillation in the OPERA Trial , 2013, Journal of the American Heart Association.

[524]  S. Ernst,et al.  Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale. , 2012, American heart journal.

[525]  D. Atar,et al.  Pharmacological conversion of recent-onset atrial fibrillation: A systematic review , 2013, Scandinavian cardiovascular journal. Supplement.

[526]  P B Corr,et al.  The surgical treatment of atrial fibrillation. II. Intraoperative electrophysiologic mapping and description of the electrophysiologic basis of atrial flutter and atrial fibrillation. , 1991, The Journal of thoracic and cardiovascular surgery.

[527]  Barry J Maron,et al.  Hypertrophic cardiomyopathy: present and future, with translation into contemporary cardiovascular medicine. , 2014, Journal of the American College of Cardiology.

[528]  A. Jugessur,et al.  Resting heart rate and physical activity as risk factors for lone atrial fibrillation: a prospective study of 309 540 men and women , 2013, Heart.

[529]  Christopher X. Wong,et al.  Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies , 2016, British Medical Journal.

[530]  David M Herrington,et al.  Atrial fibrillation and the risk of myocardial infarction. , 2015, JAMA internal medicine.

[531]  Haibo Zhang,et al.  Analysis of risk factors for recurrence after video-assisted pulmonary vein isolation of lone atrial fibrillation--results of 5 years of follow-up. , 2014, The Journal of thoracic and cardiovascular surgery.

[532]  G. Lip,et al.  Outcomes in a Warfarin-Treated Population With Atrial Fibrillation. , 2016, JAMA cardiology.

[533]  J. Svendsen,et al.  Atrial fibrillation: the role of common and rare genetic variants , 2013, European Journal of Human Genetics.

[534]  S. Kapa,et al.  Sleep apnea and atrial fibrillation: the autonomic link. , 2009, Journal of the American College of Cardiology.

[535]  G. Lamas.  How much atrial fibrillation is too much atrial fibrillation? , 2012, The New England journal of medicine.

[536]  M. Russo,et al.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation. , 1997, Circulation.

[537]  R. Mahajan,et al.  Impact of CARDIOrespiratory FITness on Arrhythmia Recurrence in Obese Individuals With Atrial Fibrillation: The CARDIO-FIT Study. , 2015, Journal of the American College of Cardiology.

[538]  J. Seger,et al.  Novel PRKAG2 Mutation Responsible for the Genetic Syndrome of Ventricular Preexcitation and Conduction System Disease With Childhood Onset and Absence of Cardiac Hypertrophy , 2001, Circulation.

[539]  Haran Burri,et al.  Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis. , 2003, Journal of the American College of Cardiology.

[540]  R. de Caterina,et al.  Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial , 2014, Circulation.

[541]  M. Bulsara,et al.  Ablate and pace strategy for atrial fibrillation: long-term outcome of AIRCRAFT trial. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[542]  P. Tchou,et al.  Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks. , 2000, Circulation.

[543]  V. Ranieri,et al.  Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. , 2011, Journal of cardiothoracic and vascular anesthesia.

[544]  A. Manolis,et al.  Supraventricular tachycardia. Mechanisms and therapy. , 1987 .

[545]  Jeroen J. Bax,et al.  2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Blood pressure.

[546]  M. Price,et al.  Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. , 2014, Journal of the American College of Cardiology.

[547]  J E Ware,et al.  Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. , 1998, Journal of clinical epidemiology.

[548]  R. Tieleman,et al.  An integrated chronic care program for patients with atrial fibrillation: study protocol and methodology for an ongoing prospective randomised controlled trial. , 2010, International journal of nursing studies.

[549]  L. Weisberg.  Atrial fibrillation in hemodialysis patients: clinical features and associations with anticoagulant therapy , 2011 .

[550]  P B Corr,et al.  The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. , 1991, The Journal of thoracic and cardiovascular surgery.

[551]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[552]  M. Russo,et al.  Histological substrate of human atrial fibrillation. , 2010, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[553]  Curt D. Furberg,et al.  Physical Activity and Incidence of Atrial Fibrillation in Older Adults: The Cardiovascular Health Study , 2008, Circulation.

[554]  Y. Li,et al.  Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial. , 2010, European heart journal.

[555]  J Raftery,et al.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. , 2005, Health technology assessment.

[556]  B. Maron,et al.  Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.

[557]  Jun Zhu,et al.  Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants Compared With Uninterrupted Vitamin K Antagonists in Patients Undergoing Catheter Ablation for Atrial Fibrillation. , 2016, The American journal of cardiology.

[558]  B. Gersh,et al.  Catheter Ablation for Atrial Fibrillation in Patients With Obesity , 2008, Circulation.

[559]  D. Levy,et al.  Obesity and the risk of new-onset atrial fibrillation. , 2004, JAMA.

[560]  S. Stewart,et al.  Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management? , 2013, Heart.

[561]  D. Levy,et al.  Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. , 1998, Circulation.

[562]  L. Køber,et al.  Bleeding After Initiation of Multiple Antithrombotic Drugs, Including Triple Therapy, in Atrial Fibrillation Patients Following Myocardial Infarction and Coronary Intervention: A Nationwide Cohort Study , 2012, Circulation.

[563]  A. Camm,et al.  An update and current expert opinions on percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[564]  P. Kirchhof,et al.  Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis--data from the German Competence Network on Atrial Fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[565]  Daniel Levy,et al.  Arrhythmias: abstractA risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community. The Framingham Heart Study☆ , 2003 .

[566]  Julie Redfern,et al.  Screening to identify unknown atrial fibrillation , 2013, Thrombosis and Haemostasis.

[567]  H. S. Kim,et al.  Mitral annulus velocity in the evaluation of left ventricular diastolic function in atrial fibrillation. , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[568]  P. Gorelick,et al.  HRS/NSA 2014 survey of atrial fibrillation and stroke: Gaps in knowledge and perspective, opportunities for improvement. , 2015, Heart rhythm.

[569]  P. Ponikowski,et al.  [2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]. , 2016, Kardiologia polska.

[570]  S. Yusuf,et al.  Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial , 2010, The Lancet Neurology.

[571]  D. Linz.  Atrial fibrillation in obstructive sleep apnea: atrial arrhythmogenic substrate of a different sort. , 2012, The American journal of cardiology.

[572]  S. Koshy,et al.  Safety and Efficacy of Ibutilide in Cardioversion of Atrial Flutter and Fibrillation , 2011, The Journal of the American Board of Family Medicine.

[573]  G. Lip,et al.  Improved outcomes with European Society of Cardiology guideline-adherent antithrombotic treatment in high-risk patients with atrial fibrillation: a report from the EORP-AF General Pilot Registry. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[574]  H. Calkins,et al.  Meta-analysis of ablation of atrial flutter and supraventricular tachycardia. , 2010, The American journal of cardiology.

[575]  J. Piccini,et al.  Atrial fibrillation in heart failure: what should we do? , 2015, European heart journal.

[576]  J. Deharo,et al.  tude clinique etlectrophysiologique dusyndrome deWolff-Parkinson-White asymptomatique , 2007 .

[577]  D. Mukherjee,et al.  Pharmacologic Rate versus Rhythm‐Control Strategies in Atrial Fibrillation: An Updated Comprehensive Review and Meta‐Analysis , 2013, Pacing and clinical electrophysiology : PACE.

[578]  Panos Vardas,et al.  The atrial fibrillation ablation pilot study: a European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association. , 2014, European heart journal.

[579]  Wouter-Jan Rappel,et al.  Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (Conventional Ablation for Atrial Fibrillation With or Without Focal Impulse and Rotor Modulation) trial. , 2012, Journal of the American College of Cardiology.

[580]  P. Claus,et al.  The Use of Cardiac Magnetic Resonance Imaging in the Diagnostic Workup and Treatment of Atrial Fibrillation , 2012, Cardiology research and practice.

[581]  Kennedy R. Lees,et al.  Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis , 2014, Stroke.

[582]  H. Wellens,et al.  Aborted sudden death in the Wolff-Parkinson-White syndrome. , 1995, The American journal of cardiology.

[583]  Paul L. Hess,et al.  Contemporary Management of Atrial Fibrillation: What Can Clinical Registries Tell Us About Stroke Prevention and Current Therapeutic Approaches? , 2014, Journal of the American Heart Association.

[584]  I. V. Van Gelder,et al.  Contemporary Reviews in Cardiovascular Medicine Symptoms and Functional Status of Patients With Atrial Fibrillation State of the Art and Future Research Opportunities , 2012 .

[585]  P. Gorelick,et al.  HRS/NSA 2014 Survey of Atrial Fibrillation and Stroke: Gaps in Knowledge and Perspective, Opportunities for Improvement. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[586]  G. Fonarow,et al.  Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort. , 2015, Journal of the American College of Cardiology.

[587]  W. Shen,et al.  Overview of Management of Atrial Fibrillation in Symptomatic Elderly Patients: Pharmacologic Therapy Versus AV Node Ablation , 2007, Clinical pharmacology and therapeutics.

[588]  X. Badia,et al.  Variation in quality of life with type of atrial fibrillation. , 2010, Revista espanola de cardiologia.

[589]  Pietro Delise,et al.  Recommendations for participation in leisure-time physical activity and competitive sports in patients with arrhythmias and potentially arrhythmogenic conditions Part I: Supraventricular arrhythmias and pacemakers , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[590]  H Kratzer,et al.  Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation. , 1998, The American journal of cardiology.

[591]  S. Siu,et al.  Recurrence rates of arrhythmias during pregnancy in women with previous tachyarrhythmia and impact on fetal and neonatal outcomes. , 2006, The American journal of cardiology.

[592]  Albert Hofman,et al.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. , 2013, European heart journal.

[593]  M. Bulsara,et al.  The Australian Intervention Randomized Control of Rate in Atrial Fibrillation Trial (AIRCRAFT). , 2003, Journal of the American College of Cardiology.

[594]  S. Priori,et al.  Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. , 2007, Heart rhythm.

[595]  A. Camm,et al.  A Comparison of Intravenous Propafenone and Flecainide in the Treatment of Tachycardias Associated with the Wolff‐Parkinson‐White Syndrome , 1991, Pacing and clinical electrophysiology : PACE.

[596]  Christopher R. Ellis,et al.  Common atrial fibrillation risk alleles at 4q25 predict recurrence after catheter-based atrial fibrillation ablation. , 2013, Heart rhythm.

[597]  Mårten Rosenqvist,et al.  Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. , 2012, European heart journal.

[598]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[599]  Ursula Ravens,et al.  Effects of IKur blocker MK-0448 on human right atrial action potentials from patients in sinus rhythm and in permanent atrial fibrillation , 2014, Front. Pharmacol..

[600]  S. Themistoclakis,et al.  Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management: Results From the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) Rand , 2014, Circulation.

[601]  A. Keech,et al.  Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis. , 2006, European heart journal.

[602]  P. Sanders,et al.  Complications of Catheter Ablation of Atrial Fibrillation: A Systematic Review , 2013, Circulation. Arrhythmia and electrophysiology.

[603]  M. Pfeffer,et al.  Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.

[604]  G. Lip,et al.  Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study). , 2014, The American journal of cardiology.

[605]  J. Triedman,et al.  Mechanism and Ablation of Arrhythmia Following Total Cavopulmonary Connection , 2015, Circulation. Arrhythmia and electrophysiology.

[606]  Ali Ahmed,et al.  Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial , 2006, Circulation.

[607]  Glenn Salkeld,et al.  Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies , 2014, Thrombosis and Haemostasis.

[608]  D. Siegal,et al.  Laboratory measurement of the anticoagulant activity of the non-vitamin K oral anticoagulants. , 2014, Journal of the American College of Cardiology.

[609]  G. Breithardt,et al.  Atrial Arrhythmias in Long‐QT Syndrome under Daily Life Conditions: A Nested Case Control Study , 2009, Journal of cardiovascular electrophysiology.

[610]  P. Kirchhof,et al.  Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation. , 2009, Journal of the American College of Cardiology.

[611]  D. Goff,et al.  Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study). , 2014, The American journal of cardiology.

[612]  P. Pibarot,et al.  A Simple Doppler Echocardiography Method to Evaluate Pulmonary Capillary Wedge Pressure in Patients with Atrial Fibrillation , 2007, Echocardiography.

[613]  K. Lunetta,et al.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation , 2012, Nature Genetics.

[614]  A. Dello Russo,et al.  Gender-related differences in catheter ablation of atrial fibrillation. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[615]  H. Tse,et al.  Prospective randomized comparison between a fixed '2C3L' approach vs. stepwise approach for catheter ablation of persistent atrial fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[616]  O. Ziff,et al.  Digoxin: The good and the bad. , 2016, Trends in cardiovascular medicine.

[617]  R. Lazzara,et al.  Spontaneous Pulmonary Vein Firing in Man: Relationship to Tachycardia‐Pause Early Afterdepolarizations and Triggered Arrhythmia in Canine Pulmonary Veins In Vitro , 2007, Journal of cardiovascular electrophysiology.

[618]  D. Singer,et al.  Warfarin Discontinuation After Starting Warfarin for Atrial Fibrillation , 2010, Circulation. Cardiovascular quality and outcomes.

[619]  Tom Wong,et al.  A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in heart failure. , 2013, Journal of the American College of Cardiology.

[620]  Geoffrey Lee,et al.  Low Risk of Major Complications Associated With Pulmonary Vein Antral Isolation for Atrial Fibrillation: Results of 500 Consecutive Ablation Procedures in Patients With Low Prevalence of Structural Heart Disease From a Single Center , 2010, Journal of cardiovascular electrophysiology.

[621]  G. Fink,et al.  Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. , 2015, JAMA.

[622]  L. Henry,et al.  The state of surgical ablation for atrial fibrillation in patients with mitral valve disease , 2013, Current opinion in cardiology.

[623]  R. de Caterina,et al.  What is 'valvular' atrial fibrillation? A reappraisal. , 2014, European heart journal.

[624]  P. Kirchhof,et al.  Predictable and less predictable unwanted cardiac drugs effects: individual pre-disposition and transient precipitating factors. , 2010, Basic & clinical pharmacology & toxicology.

[625]  O. Alfieri,et al.  Guidelines on the management of valvular heart disease (version 2012). , 2012, European heart journal.

[626]  Richard A. Kronmal,et al.  N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial Fibrillation: The Cardiovascular Health Study , 2009, Circulation.

[627]  K. Ellenbogen,et al.  Minimally invasive surgery using bipolar radiofrequency energy is effective treatment for refractory atrial fibrillation. , 2012, The Annals of thoracic surgery.

[628]  D. Roden,et al.  Symptomatic response to antiarrhythmic drug therapy is modulated by a common single nucleotide polymorphism in atrial fibrillation. , 2010, Journal of the American College of Cardiology.

[629]  J. Plumb,et al.  Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients , 2011, Thrombosis and Haemostasis.

[630]  Prashanthan Sanders,et al.  Catheter ablation of atrial arrhythmias: state of the art , 2012, The Lancet.

[631]  R. Charnigo,et al.  Increased mortality among patients taking digoxin--analysis from the AFFIRM study. , 2013, European heart journal.

[632]  S. Costanzo,et al.  Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis. , 2013, The Journal of thoracic and cardiovascular surgery.

[633]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[634]  E. Soliman,et al.  High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study. , 2015, American heart journal.

[635]  L. Køber,et al.  Thromboembolic risk in 16 274 atrial fibrillation patients undergoing direct current cardioversion with and without oral anticoagulant therapy. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[636]  N. Peters,et al.  Arrhythmias after the Fontan procedure , 1992, British heart journal.

[637]  Oral disopyramide for the acute treatment of severe outflow obstruction in hypertrophic cardiomyopathy in the ICU setting. , 2008, Chest.

[638]  M. Hirai,et al.  Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[639]  Akshay S. Desai,et al.  Angiotensin-neprilysin inhibition versus enalapril in heart failure. , 2014, The New England journal of medicine.

[640]  J. Mega,et al.  Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial , 2009, The Lancet.

[641]  K. Phan,et al.  New-onset atrial fibrillation following coronary bypass surgery predicts long-term mortality: a systematic review and meta-analysis. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[642]  R. Asinger,et al.  Warfarin in atrial fibrillation patients with moderate chronic kidney disease. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[643]  笹本 貴広,et al.  108)高度房室ブロックによる意識消失発作で発症した悪性リンパ腫の一例(日本循環器学会 第182回関東甲信越地方会) , 2002 .

[644]  G. Marcus,et al.  Healthcare Utilization and Clinical Outcomes after Catheter Ablation of Atrial Flutter , 2014, PloS one.

[645]  W. Hemmer,et al.  Approaching a paradigm shift: endoscopic ablation of lone atrial fibrillation on the beating heart. , 2012, The Annals of thoracic surgery.

[646]  S. Stewart,et al.  Women Versus Men with Chronic Atrial Fibrillation: Insights from the Standard Versus Atrial Fibrillation spEcific managemenT studY (SAFETY) , 2013, PloS one.

[647]  P. Jaumin,et al.  [Rhythm disorders occurring after surgical closure of the interatrial communication]. , 1975, Acta cardiologica.

[648]  H. Billett,et al.  Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. , 2009, The American journal of geriatric pharmacotherapy.

[649]  P. Kirchhof,et al.  and ESC CRT R&D and European Affairs Work Shop on Personalized Medicine , 2014 .

[650]  G. Lip,et al.  Antithrombotic therapy in hypertension: a Cochrane Systematic review , 2005, Journal of Human Hypertension.

[651]  G. Breithardt,et al.  A trial of self-adhesive patch electrodes and hand-held paddle electrodes for external cardioversion of atrial fibrillation (MOBIPAPA). , 2005, European heart journal.

[652]  B. Gersh,et al.  Long-Term Survival after Ablation of the Atrioventricular Node and Implantation of a Permanent Pacemaker in Patients with Atrial Fibrillation , 2001 .

[653]  Lennart Bergfeldt,et al.  Atrial Fibrillation, Stroke Risk, and Warfarin Therapy Revisited: A Population-Based Study , 2013, Stroke.

[654]  Daniel E. Singer,et al.  Device-detected atrial fibrillation and risk for stroke: an analysis of >10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices) , 2013, European heart journal.

[655]  L. Friberg,et al.  Atrial fibrillation patients do not benefit from acetylsalicylic acid. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[656]  M. Gold.  Age as a Risk Factor for Stroke in Atrial Fibrillation Patients: Implications for Thromboprophylaxis , 2011 .

[657]  J. Brugada,et al.  Ventricular Fibrillation and Sudden Death After Radiofrequency Catheter Ablation of the Atrioventricular Junction , 1997, Pacing and clinical electrophysiology : PACE.

[658]  K. Phan,et al.  Thoracoscopic surgical ablation versus catheter ablation for atrial fibrillation. , 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[659]  G. Breithardt,et al.  Anterior-posterior versus anterior-lateral electrode positions for external cardioversion of atrial fibrillation: a randomised trial , 2002, The Lancet.

[660]  Christopher Piorkowski,et al.  Tailored Atrial Substrate Modification Based on Low-Voltage Areas in Catheter Ablation of Atrial Fibrillation , 2014, Circulation. Arrhythmia and electrophysiology.

[661]  Vincenzo Di Lazzaro,et al.  Predictors for atrial fibrillation detection after cryptogenic stroke , 2016, Neurology.

[662]  C. Morillo,et al.  The prevalence and risk factors for atrioesophageal fistula after percutaneous radiofrequency catheter ablation for atrial fibrillation: the Canadian experience , 2014, Journal of Interventional Cardiac Electrophysiology.

[663]  J. Ramires,et al.  Effectiveness of the Maze Procedure Using Cooled-Tip Radiofrequency Ablation in Patients With Permanent Atrial Fibrillation and Rheumatic Mitral Valve Disease , 2005, Circulation.

[664]  Andrea Mazzanti,et al.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.

[665]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.

[666]  J. McMurray,et al.  Long-term cardiovascular consequences of obesity: 20-year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study). , 2003, European heart journal.

[667]  G. Lip,et al.  Vitamin K antagonists in heart disease: Current status and perspectives (Section III) , 2013, Thrombosis and Haemostasis.

[668]  Oliver R. Segal,et al.  Is There Still a Role for Complex Fractionated Atrial Electrogram Ablation in Addition to Pulmonary Vein Isolation in Patients With Paroxysmal and Persistent Atrial Fibrillation?: Meta-Analysis of 1415 Patients , 2015, Circulation. Arrhythmia and electrophysiology.

[669]  S. Hunt,et al.  Current role for surgery in treatment of lone atrial fibrillation. , 2012, Seminars in thoracic and cardiovascular surgery.

[670]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[671]  S. Barnett,et al.  Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. , 2006, The Journal of thoracic and cardiovascular surgery.

[672]  A. Folsom,et al.  Smoking and incidence of atrial fibrillation: results from the Atherosclerosis Risk in Communities (ARIC) study. , 2011, Heart Rhythm.

[673]  Min Zhang,et al.  Pitx2-microRNA pathway that delimits sinoatrial node development and inhibits predisposition to atrial fibrillation , 2014, Proceedings of the National Academy of Sciences.

[674]  S. Hohnloser,et al.  N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). , 2013, Journal of the American College of Cardiology.

[675]  D. Singer,et al.  Gender Differences in the Risk of Ischemic Stroke and Peripheral Embolism in Atrial Fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) Study , 2005, Circulation.

[676]  A. John Camm,et al.  Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management , 2000, Journal of Interventional Cardiac Electrophysiology.

[677]  Kevin L. Thomas,et al.  Management of Postoperative Atrial Fibrillation and Subsequent Outcomes in Contemporary Patients Undergoing Cardiac Surgery: Insights From the Society of Thoracic Surgeons CAPS‐Care Atrial Fibrillation Registry , 2014, Clinical cardiology.

[678]  P. Kirchhof,et al.  Continuous Stroke Unit Electrocardiographic Monitoring Versus 24-Hour Holter Electrocardiography for Detection of Paroxysmal Atrial Fibrillation After Stroke , 2012, Stroke.

[679]  A. Nussbacher,et al.  Atrial fibrillation in endomyocardial fibrosis is a marker of worse prognosis. , 1998, International journal of cardiology.

[680]  R. Barr,et al.  Cell size and communication: role in structural and electrical development and remodeling of the heart. , 2004, Heart rhythm.

[681]  M. Movahed,et al.  Prevention of Post–Coronary Artery Bypass Grafting (CABG) Atrial Fibrillation: Efficacy of Prophylactic Beta‐Blockers in the Modern Era , 2013, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[682]  J. Healey,et al.  Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. , 2014, JAMA.

[683]  M. Pfeffer,et al.  Irbesartan in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[684]  Michael J Ackerman,et al.  Prevalence of early-onset atrial fibrillation in congenital long QT syndrome. , 2008, Heart rhythm.

[685]  A. Laupacis,et al.  A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. , 2003, Archives of internal medicine.

[686]  Aibin Tao,et al.  Polyunsaturated fatty acids for the prevention of atrial fibrillation after cardiac surgery: an updated meta-analysis of randomized controlled trials. , 2014, Journal of cardiology.

[687]  M. Zakkar,et al.  Is perioperative corticosteroid administration associated with a reduced incidence of postoperative atrial fibrillation in adult cardiac surgery? , 2014, Interactive cardiovascular and thoracic surgery.

[688]  G. Breithardt,et al.  Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy. , 2008, European heart journal.

[689]  J. Tolstrup,et al.  Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study , 2011, Thrombosis and Haemostasis.

[690]  G. Breithardt,et al.  Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. , 2004, European heart journal.

[691]  Gustavo Saposnik,et al.  Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis , 2015, The Lancet Neurology.

[692]  L. Tamariz,et al.  Pharmacological rate control of atrial fibrillation. , 2004, Cardiology clinics.

[693]  H. Calkins,et al.  Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. , 2011, Journal of the American College of Cardiology.

[694]  D. Lambrechts,et al.  The Association of the 4q25 Susceptibility Variant for Atrial Fibrillation With Stroke Is Limited to Stroke of Cardioembolic Etiology , 2010, Stroke.

[695]  V. Santinelli,et al.  A randomized study of prophylactic catheter ablation in asymptomatic patients with the wolff-parkinson-white syndrome , 2004 .

[696]  Dante Morra,et al.  A review of the cost of atrial fibrillation. , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[697]  R. Cheung.  Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators. , 1998, JAMA.

[698]  A. Goette,et al.  Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. , 2000, Journal of the American College of Cardiology.

[699]  K. Matschke,et al.  Human Electrophysiological and Pharmacological Properties of XEN-D0101: A Novel Atrial-Selective Kv1.5/IKur Inhibitor , 2013, Journal of cardiovascular pharmacology.

[700]  J. Haefliger,et al.  Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria. , 2001, Journal of the American College of Cardiology.

[701]  A. Shipolini,et al.  Does posterior pericardiotomy reduce the incidence of atrial fibrillation after coronary artery bypass grafting surgery? , 2012, Interactive cardiovascular and thoracic surgery.

[702]  G. Breithardt,et al.  Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment , 2016, Nature Reviews Cardiology.

[703]  Panos Vardas,et al.  Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). , 2014, European heart journal.

[704]  Habib Gamra,et al.  Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry , 2011, Heart.

[705]  Giuseppe Mancia,et al.  Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group ‘Hypertension Arrhythmias and Thrombosis’ of the European Society of Hypertension , 2012, Journal of hypertension.

[706]  G. Lip,et al.  Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. , 2015, Journal of the American College of Cardiology.

[707]  M. Galvani,et al.  Atrial fibrillation after typical atrial flutter ablation: a long-term follow-up , 2011, Journal of cardiovascular medicine.

[708]  H. Crijns,et al.  A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation , 2002 .

[709]  Xu Meng,et al.  Minimally Invasive Surgical Versus Catheter Ablation for the Long-Lasting Persistent Atrial Fibrillation , 2011, PloS one.

[710]  P. C. Viswanathan,et al.  Mutation in Glycerol-3-Phosphate Dehydrogenase 1–Like Gene (GPD1-L) Decreases Cardiac Na+ Current and Causes Inherited Arrhythmias , 2007, Circulation.

[711]  M. Akaike,et al.  Clinical utility of single-beat E/e' obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function. , 2009, JACC. Cardiovascular imaging.

[712]  Chenhui Lu,et al.  Genotype-Guided Dosing of Coumarin Anticoagulants , 2015, Journal of cardiovascular pharmacology and therapeutics.

[713]  A. Goette,et al.  Atrial Amyloidosis: An Arrhythmogenic Substrate for Persistent Atrial Fibrillation , 2002, Circulation.

[714]  W. Rogers,et al.  Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. , 1989, The New England journal of medicine.

[715]  J. Brugada,et al.  Long-lasting sport practice and lone atrial fibrillation. , 2002, European heart journal.

[716]  A. Terzic,et al.  Human KATP channelopathies: diseases of metabolic homeostasis , 2009, Pflügers Archiv - European Journal of Physiology.

[717]  M. Pfeffer,et al.  Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial , 2006, The Lancet.

[718]  G. Lip,et al.  Contemporary real life cardioversion of atrial fibrillation: Results from the multinational RHYTHM-AF study. , 2014, International journal of cardiology.

[719]  M. Santini,et al.  Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study. , 1996, Journal of the American College of Cardiology.

[720]  J. Brachmann,et al.  Cryoballoon versus RF Ablation in Paroxysmal Atrial Fibrillation: Results from the German Ablation Registry , 2014, Journal of cardiovascular electrophysiology.

[721]  S. Daskalopoulou,et al.  Ranolazine Enhances the Antiarrhythmic Activity of Amiodarone by Accelerating Conversion of New-Onset Atrial Fibrillation After Cardiac Surgery , 2013, Angiology.

[722]  K. Clément,et al.  Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines. , 2015, European heart journal.

[723]  A. Laupacis,et al.  Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. , 1999, Archives of internal medicine.

[724]  M. Metra,et al.  Obstructive sleep apnoea–hypopnoea and arrhythmias: new updates , 2017, Journal of cardiovascular medicine.

[725]  G. Breithardt,et al.  The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[726]  P. Kirchhof,et al.  The European Heart Rhythm Association symptom classification for atrial fibrillation: validation and improvement through a simple modification , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[727]  H. Heidbuchel,et al.  Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[728]  P. Mohler,et al.  Defining the Role of Oxidative Stress in Atrial Fibrillation and Diabetes , 2015, Journal of cardiovascular electrophysiology.

[729]  M. Rosenqvist,et al.  Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation. , 2010, European heart journal.

[730]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[731]  J. Seara,et al.  Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter , 2014, Clinical Research in Cardiology.

[732]  T. Chao,et al.  Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. , 2010, The American journal of cardiology.

[733]  A. Camm,et al.  Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[734]  G. Lip,et al.  Gender-related differences in presentation, treatment and long-term outcome in patients with first-diagnosed atrial fibrillation and structurally normal heart: the Belgrade atrial fibrillation study. , 2012, International journal of cardiology.

[735]  D. Dobrev,et al.  The G Protein–Gated Potassium Current IK,ACh Is Constitutively Active in Patients With Chronic Atrial Fibrillation , 2005, Circulation.

[736]  Joseph D. Kay,et al.  Arrhythmia Burden in Adults With Surgically Repaired Tetralogy of Fallot: A Multi-Institutional Study , 2010, Circulation.

[737]  G. Breithardt,et al.  Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .

[738]  J. Dearani,et al.  Surgical management of atrial tachyarrhythmias associated with congenital cardiac anomalies: Mayo Clinic experience. , 2003, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[739]  K. Koskinas,et al.  Comparison of effectiveness of ranolazine plus amiodarone versus amiodarone alone for conversion of recent-onset atrial fibrillation. , 2012, The American journal of cardiology.

[740]  J. Hanley.  Warfarin reversal , 2004, Journal of Clinical Pathology.

[741]  Jun Zhu,et al.  Apixaban in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[742]  H. Diener,et al.  Antiplatelet therapy in cerebrovascular disorders. , 2012, Handbook of experimental pharmacology.

[743]  M. Zálešák,et al.  Higher Persistence in Newly Diagnosed Nonvalvular Atrial Fibrillation Patients Treated With Dabigatran Versus Warfarin , 2013, Circulation. Cardiovascular quality and outcomes.

[744]  T. Sacchi,et al.  Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. , 2003, International journal of cardiology.

[745]  R. Thadhani,et al.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. , 2009, Journal of the American Society of Nephrology : JASN.

[746]  Á. Avezum,et al.  Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES. , 2015, European heart journal.

[747]  Michael Glikson,et al.  EHRA / EAPCI expert consensus statement on catheter-based left atrial appendage occlusion , 2014 .

[748]  L. Fauchier,et al.  Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials , 2013, Current opinion in cardiology.

[749]  A. Camm,et al.  XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation , 2015, European heart journal.

[750]  M. Josephson,et al.  Amiodarone versus sotalol for atrial fibrillation. , 2005, The New England journal of medicine.

[751]  T. Potpara,et al.  Left atrial appendage closure-indications, techniques, and outcomes: results of the European Heart Rhythm Association Survey. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[752]  G. Breithardt,et al.  Factors associated with major bleeding events: insights from the ROCKET AF trial (rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). , 2014, Journal of the American College of Cardiology.

[753]  P. Kowey,et al.  Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. , 2010, JAMA.

[754]  P. Loewen,et al.  Risk of bleeding with oral anticoagulants: an updated systematic review and performance analysis of clinical prediction rules , 2011, Annals of Hematology.

[755]  K. Karason,et al.  Heart rate variability in obesity and the effect of weight loss. , 1999, The American journal of cardiology.

[756]  K. Ellenbogen,et al.  Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias. , 1998, The American journal of cardiology.

[757]  Wen-gang Yang,et al.  The Use of Statins to Prevent Postoperative Atrial Fibrillation After Coronary Artery Bypass Grafting: A Meta-analysis of 12 Studies , 2014, Journal of cardiovascular pharmacology.

[758]  Nina Ghosh,et al.  The acute treatment of maternal supraventricular tachycardias during pregnancy: a review of the literature. , 2011, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[759]  S. Pinski,et al.  A comparison of 50-J versus 100-J shocks for direct-current cardioversion of atrial flutter. , 1999, American heart journal.

[760]  Moshe Hoshen,et al.  Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation , 2015, Journal of the American Heart Association.

[761]  B. Reichart,et al.  Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[762]  G. Wassmer,et al.  Preoperative statin therapy for patients undergoing cardiac surgery. , 2012, The Cochrane database of systematic reviews.

[763]  Marlene R. Miller,et al.  The evidence regarding the drugs used for ventricular rate control. , 2000, The Journal of family practice.

[764]  L. See,et al.  Association of metformin with lower atrial fibrillation risk among patients with type 2 diabetes mellitus: a population-based dynamic cohort and in vitro studies , 2014, Cardiovascular Diabetology.

[765]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[766]  T. Ngarmukos,et al.  Predictors of Sinus Rhythm after Radiofrequency Maze and Mitral Valve Surgery , 2008, Asian cardiovascular & thoracic annals.

[767]  M. Mack,et al.  Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation , 2007, Journal of Interventional Cardiac Electrophysiology.

[768]  Pamela J. McCabe.  What patients want and need to know about atrial fibrillation , 2011, Journal of multidisciplinary healthcare.

[769]  D. Tamborero,et al.  Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[770]  Gerhard Hindricks,et al.  Performance of a New Leadless Implantable Cardiac Monitor in Detecting and Quantifying Atrial Fibrillation Results of the XPECT Trial , 2010, Circulation. Arrhythmia and electrophysiology.

[771]  J. Maessen,et al.  The hybrid approach for the surgical treatment of lone atrial fibrillation: One-year results employing a monopolar radiofrequency source , 2012, Journal of Cardiothoracic Surgery.

[772]  Y. Jinchuan,et al.  Impact of Body Mass Index on Atrial Fibrillation Recurrence: A Meta‐analysis of Observational Studies , 2013, Pacing and clinical electrophysiology : PACE.

[773]  J. Sturdivant.  Atrial Arrhythmias in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia and Ventricular Tachycardia , 2011 .

[774]  C. Clase,et al.  Systematic review and meta-analysis of incidence, prevalence and outcomes of atrial fibrillation in patients on dialysis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[775]  P. Gillette,et al.  Acute cardiac arrhythmias following surgery for congenital heart disease: mechanisms, diagnostic tools, and management. , 2011, Critical care nursing clinics of North America.

[776]  H. Wichmann,et al.  Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. , 2008, The Journal of clinical investigation.

[777]  H. Polo Friz,et al.  The definition of valvular and non-valvular atrial fibrillation: results of a physicians' survey. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[778]  H. Hod,et al.  Treatment of Stable Atrial Fibrillation in the Emergency Department: A Population-Based Comparison of Electrical Direct-Current versus Pharmacological Cardioversion or Conservative Management , 2008, Cardiology.

[779]  France Légaré,et al.  Decision aids for people facing health treatment or screening decisions. , 2017, The Cochrane database of systematic reviews.

[780]  G. Lip,et al.  Accuracy of diagnosing atrial fibrillation on electrocardiogram by primary care practitioners and interpretative diagnostic software: analysis of data from screening for atrial fibrillation in the elderly (SAFE) trial , 2007, BMJ : British Medical Journal.

[781]  Martin Borggrefe,et al.  Short QT Syndrome: A Familial Cause of Sudden Death , 2003, Circulation.

[782]  K. Lunetta,et al.  Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. , 2014, Journal of the American College of Cardiology.

[783]  M. Pirmohamed,et al.  Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. , 2009, Pharmacogenomics.

[784]  Prashanthan Sanders,et al.  Frequency Mapping of the Pulmonary Veins in Paroxysmal Versus Permanent Atrial Fibrillation , 2006, Journal of cardiovascular electrophysiology.

[785]  Stephan Willems,et al.  Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. , 2009, European heart journal.

[786]  G. Breithardt,et al.  Impact of the type of centre on management of AF patients: Surprising evidence for differences in antithrombotic therapy decisions , 2011, Thrombosis and Haemostasis.

[787]  S. Johnston,et al.  Estimation of Total Incremental Health Care Costs in Patients With Atrial Fibrillation in the United States , 2011, Circulation. Cardiovascular quality and outcomes.

[788]  J. Olesen,et al.  Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study , 2015, BMJ : British Medical Journal.

[789]  M. Keltai,et al.  Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trial. , 2012, European heart journal.

[790]  Christopher X. Wong,et al.  Long-Term Effect of Goal-Directed Weight Management in an Atrial Fibrillation Cohort: A Long-Term Follow-Up Study (LEGACY). , 2015, Journal of the American College of Cardiology.

[791]  G. Lip,et al.  Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study. , 2009, European heart journal.

[792]  Ashok J. Shah,et al.  Driver Domains in Persistent Atrial Fibrillation , 2014, Circulation.

[793]  Eric E. Smith,et al.  Risks of intracranial hemorrhage among patients with acute ischemic stroke receiving warfarin and treated with intravenous tissue plasminogen activator. , 2012, JAMA.

[794]  D. Giachino,et al.  Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis. , 2014, Heart rhythm.

[795]  Mark E. Anderson,et al.  Progress toward the prevention and treatment of atrial fibrillation: A summary of the Heart Rhythm Society Research Forum on the Treatment and Prevention of Atrial Fibrillation, Washington, DC, December 9-10, 2013. , 2015, Heart rhythm.

[796]  J. Vogt,et al.  Predictors of Recurrence in Patients Undergoing Cryoballoon Ablation for Treatment of Atrial Fibrillation: The Independent Role of Sleep‐Disordered Breathing , 2011, Journal of cardiovascular electrophysiology.

[797]  G. Hindricks,et al.  Chromosome 4q25 variants and atrial fibrillation recurrence after catheter ablation. , 2010, Journal of the American College of Cardiology.

[798]  G. Breithardt,et al.  Higher risk of death and stroke in patients with persistent vs. paroxysmal atrial fibrillation: results from the ROCKET-AF Trial , 2014, European heart journal.

[799]  G. Lip,et al.  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial , 2007, The Lancet.

[800]  S. Connolly,et al.  Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.

[801]  D. Dutka,et al.  Mechanisms of atrial mitral regurgitation: insights using 3D transoesophageal echo. , 2014, European heart journal cardiovascular Imaging.

[802]  G. Lip,et al.  TRial of an Educational intervention on patients' knowledge of Atrial fibrillation and anticoagulant therapy, INR control, and outcome of Treatment with warfarin (TREAT) , 2010, BMC cardiovascular disorders.

[803]  A. Hobbs,et al.  Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. , 2016, International journal of cardiology.

[804]  D. Vitale,et al.  Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. , 2001, Journal of the American College of Cardiology.

[805]  Yeong-Hoon Choi,et al.  Preoperative statin therapy in cardiac surgery: a meta-analysis of 90,000 patients. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[806]  Saibal Kar,et al.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.

[807]  J. Deharo,et al.  Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR). , 2009, Archives of cardiovascular diseases.

[808]  Karen Page,et al.  A systematic approach to chronic heart failure care: a consensus statement , 2015, The Medical journal of Australia.

[809]  F. Marchlinski,et al.  Atrial flutter: more than just one of a kind. , 2015, European heart journal.

[810]  Shih‐Ann Chen,et al.  Hypoxia and reoxygenation modulate the arrhythmogenic activity of the pulmonary vein and atrium. , 2012, Clinical science.

[811]  D. Singer,et al.  Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. , 2011, European heart journal.

[812]  G. Hindricks,et al.  Atrial Arrhythmias Following Surgical AF Ablation: Electrophysiological Findings, Ablation Strategies, and Clinical Outcome , 2014, Journal of cardiovascular electrophysiology.

[813]  G. Lip,et al.  Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. , 2014, Chest.

[814]  B. Strom,et al.  Observational cohort study of the safety of digoxin use in women with heart failure , 2012, BMJ Open.

[815]  Wen-Chung Yu,et al.  Persistent Atrial Flutter in Patients Treated for Atrial Fibrillation with Amiodarone and Propafenone: , 1999, Journal of cardiovascular electrophysiology.

[816]  M. de Belder,et al.  A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is planned. , 2006, American heart journal.

[817]  D. Reda,et al.  Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial. , 2009, Heart rhythm.

[818]  Volkmar Falk,et al.  2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.

[819]  G. Boriani,et al.  Amyloid deposition as a cause of atrial remodelling in persistent valvular atrial fibrillation. , 2004, European heart journal.

[820]  Nazem Akoum,et al.  Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. , 2014, JAMA.

[821]  A. Camm,et al.  The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. , 2000, Cardiovascular research.

[822]  E. Gurfinkel,et al.  Low-molecular-weight heparin alone versus a combination of unfractionated heparin and low-molecular-weight heparin. , 2000, American heart journal.

[823]  Mark A. Wood,et al.  Efficacy and Safety of Repeated Intravenous Doses of Ibutilide for Rapid Conversion of Atrial Flutter or Fibrillation , 1996 .

[824]  R. Cappato,et al.  Surgical treatment of arrhythmias in adults with congenital heart defects. , 2008, International journal of cardiology.

[825]  P C Deedwania,et al.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. , 1995, The New England journal of medicine.

[826]  D. McDevitt,et al.  Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem. , 1988, European heart journal.

[827]  C. Antzelevitch,et al.  Atrial-selective Prolongation of Refractory Period With AVE0118 is Due Principally to Inhibition of Sodium Channel Activity , 2012, Journal of cardiovascular pharmacology.

[828]  M. Pfeffer,et al.  Prevention of atrial fibrillation in patients with symptomatic chronic heart failure by candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. , 2006, American heart journal.

[829]  Alfonso Martín,et al.  Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study. , 2005, Annals of emergency medicine.

[830]  David O. Martin,et al.  Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. , 2008, The New England journal of medicine.

[831]  D. Schwartzman,et al.  Understanding Atrial Symptom Reports: Objective versus Subjective Predictors , 2005, Pacing and clinical electrophysiology : PACE.

[832]  Elena S. Di Martino,et al.  Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment , 2001, Journal of endocrinological investigation.

[833]  A. Capucci,et al.  Effects of diltiazem pretreatment on direct-current cardioversion in patients with persistent atrial fibrillation: a single-blind, randomized, controlled study. , 2000, American Heart Journal.

[834]  J. Tolstrup,et al.  Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study , 2011, BMJ : British Medical Journal.

[835]  V. Figueredo,et al.  Tachycardia mediated cardiomyopathy: pathophysiology, mechanisms, clinical features and management. , 2014, International journal of cardiology.

[836]  Z. Lin,et al.  The effect of microwave and bipolar radio-frequency ablation in the surgical treatment of permanent atrial fibrillation during valve surgery. , 2011, The Thoracic and cardiovascular surgeon.

[837]  Dhaval Shah,et al.  Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. , 2012, Journal of the American College of Cardiology.

[838]  M. Enriquez-Sarano,et al.  Left atrial remodelling in mitral regurgitation--methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. , 2007, European heart journal.

[839]  G. Guyatt,et al.  Effectiveness of amiodarone for conversion of atrial fibrillation to sinus rhythm: a meta-analysis. , 2003, Archives of internal medicine.

[840]  G. Wander,et al.  Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection In Patients With Atrial Fibrillation) trial. , 2013 .

[841]  T. Buclin,et al.  Effect of dronedarone on renal function in healthy subjects , 2005, British Journal of Clinical Pharmacology.

[842]  Eric Anderson,et al.  Anticoagulation strategies for the management of postoperative atrial fibrillation. , 2014, Clinics in laboratory medicine.

[843]  R. Falk,et al.  Intravenous dofetilide, a class III antiarrhythmic agent, for the termination of sustained atrial fibrillation or flutter. Intravenous Dofetilide Investigators. , 1997, Journal of the American College of Cardiology.

[844]  Michel Haïssaguerre,et al.  Loss-of-Function Mutations in the Cardiac Calcium Channel Underlie a New Clinical Entity Characterized by ST-Segment Elevation, Short QT Intervals, and Sudden Cardiac Death , 2007, Circulation.

[845]  G. Lip,et al.  Atrial flutter and thromboembolic risk: a systematic review , 2015, Heart.

[846]  R. McCarthy,et al.  Systemic magnesium to reduce postoperative arrhythmias after coronary artery bypass graft surgery: a meta-analysis of randomized controlled trials. , 2012, Journal of cardiothoracic and vascular anesthesia.

[847]  M. Sherrid,et al.  Treatment of Obstructive Hypertrophic Cardiomyopathy Symptoms and Gradient Resistant to First-Line Therapy With &bgr;-Blockade or Verapamil , 2013, Circulation. Heart failure.

[848]  R. Altman,et al.  Estimation of the warfarin dose with clinical and pharmacogenetic data. , 2009, The New England journal of medicine.

[849]  Spiros Denaxas,et al.  Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care , 2016, Heart.

[850]  X. Badia,et al.  Validation of the AF-QoL, a disease-specific quality of life questionnaire for patients with atrial fibrillation. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[851]  M. Ezekowitz,et al.  Gender in atrial fibrillation: Ten years later. , 2010, Gender medicine.

[852]  C. Reid,et al.  Usefulness of postoperative atrial fibrillation as an independent predictor for worse early and late outcomes after isolated coronary artery bypass grafting (multicenter Australian study of 19,497 patients). , 2012, The American journal of cardiology.

[853]  M. Gammage,et al.  Ablate and pace revisited: long term survival and predictors of permanent atrial fibrillation , 2003, Heart.

[854]  G. Lip,et al.  Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. , 2014, Heart rhythm.

[855]  M. Chang,et al.  Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized, digoxin-controlled study. , 1995, European heart journal.

[856]  Prashanthan Sanders,et al.  Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysis , 2013, Journal of the American Heart Association.

[857]  T. Jun,et al.  Efficacy of the Maze Procedure for Atrial Fibrillation Associated with Atrial Septal Defect , 2013, The Korean journal of thoracic and cardiovascular surgery.

[858]  Elsayed Z Soliman,et al.  Association of Chronic Kidney Disease With Atrial Fibrillation Among Adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) Study , 2011, Circulation. Arrhythmia and electrophysiology.

[859]  G. Lip,et al.  Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score , 2015, Thrombosis and Haemostasis.

[860]  G. Breithardt,et al.  An international survey of physician and patient understanding, perception, and attitudes to atrial fibrillation and its contribution to cardiovascular disease morbidity and mortality , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[861]  K. Ramanathan,et al.  Prophylactic magnesium does not prevent atrial fibrillation after cardiac surgery: a meta-analysis. , 2013, The Annals of thoracic surgery.

[862]  Tom Adriaenssens,et al.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[863]  N. Mostow,et al.  Amiodarone pulmonary toxicity. , 1983, American heart journal.

[864]  Xu Meng,et al.  Ablation in selective patients with long-standing persistent atrial fibrillation: medium-term results of the Dallas lesion set. , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[865]  Yong Jin Kim,et al.  Surgical Therapy of Arrhythmias in Single‐Ventricle Patients Undergoing Fontan or Fontan Conversion , 2009, Journal of cardiac surgery.

[866]  P. Rothwell,et al.  Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis , 2007, The Lancet Neurology.

[867]  P. Lambiase,et al.  Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation. , 2016, The Cochrane database of systematic reviews.

[868]  A. Verma,et al.  Dofetilide is safe and effective in preventing atrial fibrillation recurrences in patients accepted for catheter ablation. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[869]  D. Lin,et al.  Nearly uniform failure of atrial flutter ablation and continuation of antiarrhythmic agents (hybrid therapy) for the long-term control of atrial fibrillation , 2012, Journal of Interventional Cardiac Electrophysiology.

[870]  J A ABILDSKOV,et al.  Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. , 1959, American heart journal.

[871]  S. Yusuf,et al.  Cardiac Biomarkers Are Associated With an Increased Risk of Stroke and Death in Patients With Atrial Fibrillation: A Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Substudy , 2012, Circulation.

[872]  Paul J. Wang,et al.  Safety and Efficacy of Pulmonary Vein Antral Isolation in Patients With Obstructive Sleep Apnea: The Impact of Continuous Positive Airway Pressure , 2010, Circulation. Arrhythmia and electrophysiology.

[873]  L. Magee,et al.  Oral beta-blockers for mild to moderate hypertension during pregnancy. , 2000, The Cochrane database of systematic reviews.

[874]  Lars-Åke Levin,et al.  Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[875]  A. Waldo.  Left Ventricular Dysfunction in Atrial Fibrillation: Restoration of Sinus Rhythm by the Cox-Maze Procedure Significantly Improves Systolic Function and Functional Status , 2007 .

[876]  P. Kirchhof,et al.  Management of Patients With Atrial Fibrillation by Primary‐Care Physicians in Germany: 1‐Year Results of the ATRIUM Registry , 2014, Clinical cardiology.

[877]  R. Mahajan,et al.  Catheter ablation of atrial fibrillation in patients with concomitant left ventricular impairment: a systematic review of efficacy and effect on ejection fraction. , 2015, Heart, lung & circulation.

[878]  David A Fitzmaurice,et al.  Screening versus routine practice in detection of atrial fibrillation in patients aged 65 or over: cluster randomised controlled trial , 2007, BMJ : British Medical Journal.

[879]  A. Torbicki,et al.  Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study. , 2004, Chest.

[880]  Shunichi Homma,et al.  Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort. , 2011, Journal of the American College of Cardiology.

[881]  T. Steiner,et al.  Idarucizumab for Dabigatran Reversal. , 2015, The New England journal of medicine.

[882]  C. Lau,et al.  Does sinus rhythm beget sinus rhythm? Effects of prompt cardioversion on the frequency and persistence of recurrent atrial fibrillation. , 2003, Cardiac electrophysiology review.

[883]  P. Ellinor,et al.  Twelve–Single Nucleotide Polymorphism Genetic Risk Score Identifies Individuals at Increased Risk for Future Atrial Fibrillation and Stroke , 2014, Stroke.

[884]  D. Atar,et al.  Dronedarone in high-risk permanent atrial fibrillation. , 2011, The New England journal of medicine.

[885]  Nancy R Cook,et al.  Relation of vigorous exercise to risk of atrial fibrillation. , 2009, The American journal of cardiology.

[886]  P. Kirchhof,et al.  Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data , 2015, BMJ : British Medical Journal.

[887]  F. Gaita,et al.  Very long-term results of electroanatomic-guided radiofrequency ablation of atrial arrhythmias in patients with surgically corrected atrial septal defect. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[888]  P. Batin,et al.  A randomized placebo-controlled trial of pre-treatment and short- or long-term maintenance therapy with amiodarone supporting DC cardioversion for persistent atrial fibrillation. , 2004, European heart journal.

[889]  A. Maggioni,et al.  Valsartan for prevention of recurrent atrial fibrillation. , 2009, The New England journal of medicine.

[890]  J. Dunning,et al.  Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[891]  A. Waldo.  Substrate and Procedural Predictors of Outcomes After Catheter Ablation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy , 2009 .

[892]  J. Deharo,et al.  [Clinical and electrophysiological study of asymptomatic Wolff-Parkinson-White syndrome]. , 2007, Annales de cardiologie et d'angeiologie.

[893]  A. Ahlsson,et al.  Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. , 2010, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[894]  P. Szekely.  Systemic Embolism and Anticoagulant Prophylaxis in Rheumatic Heart Disease , 1964, British medical journal.

[895]  J. McMurray,et al.  Increased mortality after dronedarone therapy for severe heart failure. , 2008, The New England journal of medicine.

[896]  J. Boineau,et al.  Successful surgical treatment of atrial fibrillation. Review and clinical update. , 1991, JAMA.

[897]  H. Melhus,et al.  Digoxin and mortality in atrial fibrillation: a prospective cohort study , 2007, European Journal of Clinical Pharmacology.

[898]  Stefan Kääb,et al.  Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol. , 2003, European heart journal.

[899]  S. Ernst,et al.  Risk of Sudden Death After Successful Accessory Atrioventricular Pathway Ablation in Resuscitated Patients with Wolff‐Parkinson‐White Syndrome , 2002, Journal of cardiovascular electrophysiology.

[900]  S. Saksena,et al.  Catheter Ablation of Inducible Atrial Flutter, in Combination with Atrial Pacing and Antiarrhythmic Drugs (“Hybrid Therapy”) Improves Rhythm Control in Patients with Refractory Atrial Fibrillation , 2002, Journal of Interventional Cardiac Electrophysiology.

[901]  M. Chung,et al.  European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[902]  O. Alfieri,et al.  [Guidelines on the management of valvular heart disease (version 2012). The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)]. , 2013, Giornale italiano di cardiologia.

[903]  I. Khan.  Oral loading single dose flecainide for pharmacological cardioversion of recent-onset atrial fibrillation. , 2003, International journal of cardiology.

[904]  Giancarlo Agnelli,et al.  Efficacy and Safety of Anticoagulant Treatment in Acute Cardioembolic Stroke: A Meta-Analysis of Randomized Controlled Trials , 2007, Stroke.

[905]  S. Connolly,et al.  Effect of dronedarone on cardiovascular events in atrial fibrillation. , 2009, The New England journal of medicine.

[906]  David Keane,et al.  2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[907]  É. Marijon,et al.  Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[908]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[909]  Christopher Piorkowski,et al.  Color-coded three-dimensional entrainment mapping for analysis and treatment of atrial macroreentrant tachycardia. , 2009, Heart rhythm.

[910]  B. Lüderitz,et al.  Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. , 2004, European heart journal.

[911]  Ashok J. Shah,et al.  Prevalence and Types of Pitfall in the Assessment of Mitral Isthmus Linear Conduction Block , 2012, Circulation. Arrhythmia and electrophysiology.

[912]  J. Olesen,et al.  Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study , 2012, Journal of thrombosis and haemostasis : JTH.

[913]  M. Molokhia,et al.  Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis , 2015, Circulation.

[914]  G. Elwyn,et al.  Shared decision making: really putting patients at the centre of healthcare , 2012, BMJ : British Medical Journal.

[915]  Gregory Y H Lip,et al.  Prevalence of atrial fibrillation in the general population and in high-risk groups: the ECHOES study. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[916]  J. Olesen,et al.  The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study , 2012, BMJ : British Medical Journal.

[917]  J. Cleland,et al.  Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial. , 2013, European heart journal.

[918]  J. Mathew,et al.  A multicenter risk index for atrial fibrillation after cardiac surgery. , 2004, JAMA.

[919]  Mårten Rosenqvist,et al.  Mass Screening for Untreated Atrial Fibrillation: The STROKESTOP Study , 2015, Circulation.

[920]  T. Palfai,et al.  Brief Intervention for Medical Inpatients with Unhealthy Alcohol Use , 2007, Annals of Internal Medicine.

[921]  M. Mack,et al.  Pulmonary vein isolation and autonomic denervation for the management of paroxysmal atrial fibrillation by a minimally invasive surgical approach. , 2010, The Journal of thoracic and cardiovascular surgery.

[922]  F. Biancari,et al.  Radiofrequency ablation vs. antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[923]  A. Glanz,et al.  Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. , 2013, The New England journal of medicine.

[924]  Erwan Donal,et al.  EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. , 2016, European heart journal cardiovascular Imaging.

[925]  Stanley Nattel,et al.  Role of the Autonomic Nervous System in Atrial Fibrillation: Pathophysiology and Therapy , 2014, Circulation research.

[926]  R. Damiano,et al.  The Cox-Maze Procedure for Lone Atrial Fibrillation: A Single-Center Experience Over 2 Decades , 2012, Circulation. Arrhythmia and electrophysiology.

[927]  Bramahn . Singh,et al.  Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. , 1999, Journal of the American College of Cardiology.

[928]  E. Antman,et al.  Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial , 2015, The Lancet.

[929]  S. Yusuf,et al.  The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study , 2016, The Lancet.

[930]  K. Koskinas,et al.  Ranolazine enhances the efficacy of amiodarone for conversion of recent-onset atrial fibrillation. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[931]  D. Levy,et al.  Lifetime Risk for Development of Atrial Fibrillation: The Framingham Heart Study , 2004, Circulation.

[932]  G. Klein,et al.  Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. , 1990, Journal of the American College of Cardiology.

[933]  K. Müller,et al.  Efficacy of an additional MAZE procedure using cooled-tip radiofrequency ablation in patients with chronic atrial fibrillation and mitral valve disease. A randomized, prospective trial. , 2002, European heart journal.

[934]  E. Aliot,et al.  Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. , 2007, The New England journal of medicine.

[935]  J. Molnar,et al.  Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis , 2008, American journal of therapeutics.

[936]  D. Singer,et al.  A new risk scheme to predict warfarin-associated hemorrhage: The ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) Study. , 2011, Journal of the American College of Cardiology.

[937]  M. Shoda,et al.  Management of late atrial tachyarrhythmia long after Fontan operation. , 2009, Journal of cardiology.

[938]  G. Hindricks,et al.  A proposal for interdisciplinary, nurse-coordinated atrial fibrillation expert programmes as a way to structure daily practice. , 2013, European heart journal.

[939]  G. Breithardt,et al.  Prolonged Atrial Action Potential Durations and Polymorphic Atrial Tachyarrhythmias in Patients with Long QT Syndrome , 2003, Journal of cardiovascular electrophysiology.

[940]  Wojciech Zareba,et al.  The HARMONY Trial: Combined Ranolazine and Dronedarone in the Management of Paroxysmal Atrial Fibrillation Mechanistic and Therapeutic Synergism , 2015, Circulation. Arrhythmia and electrophysiology.

[941]  L. Svensson,et al.  Surgery for paroxysmal atrial fibrillation in the setting of mitral valve disease: a role for pulmonary vein isolation? , 2006, The Annals of thoracic surgery.

[942]  G. Breithardt,et al.  Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[943]  S. Pocock,et al.  Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. , 2016, The New England journal of medicine.

[944]  H. Crijns,et al.  Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial. , 2008, JAMA.

[945]  A. Curcio,et al.  Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-Analysis , 2015, PloS one.

[946]  Volkmar Falk,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Ca , 2014, European heart journal.

[947]  Brian T. Austin,et al.  Organizing care for patients with chronic illness. , 1996, The Milbank quarterly.

[948]  R. Friedman,et al.  Transesophageal echocardiographic detection of atrial thrombi in patients with nonfibrillation atrial tachyarrhythmias and congenital heart disease. , 1994, Journal of the American College of Cardiology.

[949]  A. Rabinstein.  Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial , 2010 .

[950]  M. Rosenqvist,et al.  Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study. , 2007, European heart journal.

[951]  N. Alp,et al.  Randomised comparison of antero-lateral versus antero-posterior paddle positions for DC cardioversion of persistent atrial fibrillation. , 2000, International journal of cardiology.

[952]  F. Mori,et al.  Percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation: implantation and up to four years follow-up of the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[953]  J. Brugada,et al.  Impact of atrial fibrillation-induced tachycardiomyopathy in patients undergoing pulmonary vein isolation. , 2013, International journal of cardiology.

[954]  P. Calder,et al.  Omega-3 Fatty Acid Supplementation Does Not Reduce Risk of Atrial Fibrillation After Coronary Artery Bypass Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2010, Circulation. Arrhythmia and electrophysiology.

[955]  F. Rosendaal,et al.  Warfarin and aspirin after heart-valve replacement. , 1994, The New England journal of medicine.

[956]  Paulus Kirchhof,et al.  Atrial fibrillation guidelines across the Atlantic: a comparison of the current recommendations of the European Society of Cardiology/European Heart Rhythm Association/European Association of Cardiothoracic Surgeons, the American College of Cardiology Foundation/American Heart Association/Heart Rhyt , 2013, European heart journal.

[957]  K. Stangl,et al.  Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. , 2000, Journal of the American College of Cardiology.

[958]  G. Bonsel,et al.  Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) , 2011, Quality of Life Research.

[959]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[960]  Leora Peltz,et al.  Epicardial Mapping of Chronic Atrial Fibrillation in Patients: Preliminary Observations , 2004, Circulation.

[961]  D. Lane,et al.  A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice , 2011, Journal of thrombosis and haemostasis : JTH.

[962]  M. Rosenqvist,et al.  A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[963]  M. Maruthappu,et al.  How effective is bipolar radiofrequency ablation for atrial fibrillation during concomitant cardiac surgery? , 2012, Interactive cardiovascular and thoracic surgery.

[964]  Yawei Xu,et al.  Influence of Body Mass Index on Recurrence and Quality of Life in Atrial Fibrillation Patients After Catheter Ablation: A Meta‐Analysis and Systematic Review , 2013, Clinical cardiology.

[965]  Jeffrey L. Anderson,et al.  Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. , 2005, JAMA.

[966]  R. Pathak,et al.  Meta-analysis of efficacy and safety of rivaroxaban compared with warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation. , 2014, The American journal of cardiology.

[967]  R. Page,et al.  Risk stratification for arrhythmic events in patients with asymptomatic pre-excitation: A systematic review for the 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force , 2016, Heart rhythm.

[968]  A. Moss,et al.  ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. , 1995, Circulation.

[969]  W. Winkelmayer,et al.  Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[970]  J. Haines,et al.  Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation , 2008, Circulation.

[971]  John Spertus,et al.  Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful? , 2013, American heart journal.

[972]  H. Saner,et al.  Atrial remodeling, autonomic tone, and lifetime training hours in nonelite athletes. , 2011, The American journal of cardiology.

[973]  Sean M. O'Brien,et al.  Atrial fibrillation correction surgery: lessons from the Society of Thoracic Surgeons National Cardiac Database. , 2008, The Annals of thoracic surgery.

[974]  Elia Biganzoli,et al.  Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation , 2005, Circulation. Arrhythmia and electrophysiology.

[975]  E. Kholmovski,et al.  Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. , 2011, Journal of the American College of Cardiology.

[976]  Prashanthan Sanders,et al.  Epistatic effects of potassium channel variation on cardiac repolarization and atrial fibrillation risk. , 2012, Journal of the American College of Cardiology.

[977]  P. Kirchhof,et al.  Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis , 2014, The Lancet.

[978]  M. Zoni-Berisso,et al.  Epidemiology of atrial fibrillation: European perspective , 2014, Clinical epidemiology.

[979]  Stanley Nattel,et al.  The clinical profile and pathophysiology of atrial fibrillation: relationships among clinical features, epidemiology, and mechanisms. , 2014, Circulation research.

[980]  I. Gelder,et al.  Quality of life in persistent atrial fibrillation in the RACE study , 2002 .

[981]  B. Nordestgaard,et al.  Antihypertensive treatment and risk of atrial fibrillation: a nationwide study. , 2014, European heart journal.

[982]  R. Hunter,et al.  Catheter Ablation of Atrial Fibrillation in Patients With Left Ventricular Systolic Dysfunction: A Systematic Review and Meta-Analysis , 2014, Circulation. Arrhythmia and electrophysiology.

[983]  Antonio De Simone,et al.  Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). , 2006, European heart journal.

[984]  RaviMandapati,et al.  Stable Microreentrant Sources as a Mechanism of Atrial Fibrillation in the Isolated Sheep Heart , 2000 .

[985]  M. Keane,et al.  Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. , 2011, Journal of the American College of Cardiology.

[986]  Petr Neuzil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[987]  S. Yusuf,et al.  Benefit of Oral Anticoagulant Over Antiplatelet Therapy in Atrial Fibrillation Depends on the Quality of International Normalized Ratio Control Achieved by Centers and Countries as Measured by Time in Therapeutic Range , 2008, Circulation.

[988]  F. Rutten,et al.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). , 2014, European heart journal.

[989]  S. Yusuf,et al.  Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. , 2004, The Cochrane database of systematic reviews.

[990]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[991]  G. Breithardt,et al.  Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial. , 2013, American heart journal.

[992]  J. Belmin,et al.  Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. , 2015, The Cochrane database of systematic reviews.

[993]  P. Alboni,et al.  Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach , 2005 .

[994]  I. V. Van Gelder,et al.  Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial , 2015, Trials.

[995]  Bingren Gao,et al.  Comparison of pharmacological and electrical cardioversion in permanent atrial fibrillation after prosthetic cardiac valve replacement: A prospective randomized trial , 2013, The Journal of international medical research.

[996]  J. Eikelboom,et al.  Stroke prevention in atrial fibrillation patients with chronic kidney disease. , 2013, The Canadian journal of cardiology.

[997]  Ulrich Schotten,et al.  Electropathological Substrate of Long-Standing Persistent Atrial Fibrillation in Patients With Structural Heart Disease: Longitudinal Dissociation , 2010, Circulation. Arrhythmia and electrophysiology.

[998]  G. Fonarow,et al.  ACC/AHA/AACVPR/AAFP/ANA Concepts for Clinician–Patient Shared Accountability in Performance Measures: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures , 2014, Circulation.

[999]  S. de Denus,et al.  Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. , 2005, Archives of internal medicine.

[1000]  H. Alkadhi,et al.  Left atrial appendage clip occlusion: early clinical results. , 2010, The Journal of thoracic and cardiovascular surgery.

[1001]  S. Nattel,et al.  DILITIZEM INCREASES LATE-ONSET CONGESTIVE HEART FAILURE IN POSTINFARCTION PATIENTS WITH EARLY REDUCTION IN EJECTION FRACTION , 1991 .

[1002]  M. Rich,et al.  Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation. , 2000, Stroke.

[1003]  P. Lambiase,et al.  Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[1004]  G. Guyatt,et al.  Values and preferences in oral anticoagulation in patients with atrial fibrillation, physicians' and patients' perspectives: protocol for a two-phase study , 2008, BMC health services research.

[1005]  R. Mahajan,et al.  Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. , 2014, Journal of the American College of Cardiology.

[1006]  Fredrik Folke,et al.  Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. , 2010, Archives of internal medicine.

[1007]  M. Visser,et al.  Elevated C-reactive protein levels in overweight and obese adults. , 1999, JAMA.

[1008]  P. Kirchhof,et al.  Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry , 2011, Clinical Research in Cardiology.

[1009]  Dietrich Andresen,et al.  Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. , 2005, European heart journal.

[1010]  David J Gladstone,et al.  Atrial fibrillation in patients with cryptogenic stroke. , 2014, The New England journal of medicine.

[1011]  D. Ngaage,et al.  Prognostic implications of preoperative atrial fibrillation in patients undergoing aortic valve replacement: is there an argument for concomitant arrhythmia surgery? , 2006, The Annals of thoracic surgery.

[1012]  C. Mavroudis,et al.  Maze procedure in single ventricle patients. , 2008, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[1013]  Sanghamitra Mohanty,et al.  Impact of Rotor Ablation in Nonparoxysmal Atrial Fibrillation Patients: Results From the Randomized OASIS Trial. , 2016, Journal of the American College of Cardiology.

[1014]  Wen-Chung Yu,et al.  Use of enalapril to facilitate sinus rhythm maintenance after external cardioversion of long-standing persistent atrial fibrillation. Results of a prospective and controlled study. , 2003, European heart journal.

[1015]  J. Mccormack,et al.  Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. , 1996, Circulation.

[1016]  Megan Coylewright,et al.  Shared Decision Making in Atrial Fibrillation: Where We Are and Where We Should Be Going , 2014, Circulation.

[1017]  P. Sandercock,et al.  Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials | NOVA. The University of Newcastle's Digital Repository , 2014 .

[1018]  M. Simoons,et al.  Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. , 2003, European heart journal.

[1019]  A. Camm,et al.  Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[1020]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[1021]  S. Priori,et al.  Molecular and Electrophysiological Bases of Catecholaminergic Polymorphic Ventricular Tachycardia , 2007, Journal of cardiovascular electrophysiology.

[1022]  H. Schaff,et al.  Surgical ablation for atrial fibrillation for two decades: are the results of new techniques equivalent to the Cox maze III procedure? , 2014, The Journal of thoracic and cardiovascular surgery.

[1023]  J. McMurray,et al.  Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial , 2010, Heart.

[1024]  M S Spach,et al.  Initiating Reentry: , 1994, Journal of cardiovascular electrophysiology.

[1025]  H. Crijns,et al.  Nurse-led care vs. usual care for patients with atrial fibrillation: results of a randomized trial of integrated chronic care vs. routine clinical care in ambulatory patients with atrial fibrillation. , 2012, European heart journal.

[1026]  Emily C. O'Brien,et al.  The ORBIT bleeding score: a simple bedside score to assess bleeding risk in atrial fibrillation , 2015, European heart journal.

[1027]  A. Sato,et al.  Effect of eplerenone on maintenance of sinus rhythm after catheter ablation in patients with long-standing persistent atrial fibrillation. , 2013, The American journal of cardiology.

[1028]  Daniel Steven,et al.  Five-Year Follow-Up After Catheter Ablation of Persistent Atrial Fibrillation Using the Stepwise Approach and Prognostic Factors for Success , 2015, Circulation. Arrhythmia and electrophysiology.

[1029]  G. Hindricks,et al.  Value of Different Follow‐Up Strategies to Assess the Efficacy of Circumferential Pulmonary Vein Ablation for the Curative Treatment of Atrial Fibrillation , 2005, Journal of cardiovascular electrophysiology.

[1030]  Deepak L. Bhatt,et al.  The optimal management of patients on oral anticoagulation undergoing coronary artery stenting , 2014, Thrombosis and Haemostasis.

[1031]  R. Damiano,et al.  Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease. , 2012, The Annals of thoracic surgery.

[1032]  A. Waldo.  Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study , 2006 .

[1033]  Lluís Mont,et al.  Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) , 2013, European heart journal.

[1034]  E. Kaufman.  Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome. , 2009, Heart rhythm.

[1035]  G. Kay,et al.  Pulmonary vein isolation in patients with paroxysmal atrial fibrillation after direct suture closure of congenital atrial septal defect. , 2007, Circulation journal : official journal of the Japanese Circulation Society.

[1036]  John V. Wylie,et al.  Catheter Ablation for Atrial Fibrillation in Patients with Obesity. , 2008, Journal of atrial fibrillation.

[1037]  G. Lip,et al.  SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. , 2014, The American journal of medicine.

[1038]  J. Tu,et al.  Warfarin Use and the Risk for Stroke and Bleeding in Patients With Atrial Fibrillation Undergoing Dialysis , 2014, Circulation.

[1039]  Jeevanantham Rajeswaran,et al.  Surgery for permanent atrial fibrillation: impact of patient factors and lesion set. , 2006, The Annals of thoracic surgery.

[1040]  D. Gladstone,et al.  Screening for undiagnosed atrial fibrillation in the community , 2014, Current opinion in cardiology.

[1041]  J. Seara,et al.  Failure of hybrid therapy for the prevention of long-term recurrence of atrial fibrillation , 2014 .

[1042]  C. Zhang,et al.  Meta‐analysis of amiodarone versus beta‐blocker as a prophylactic therapy against atrial fibrillation following cardiac surgery , 2012, Internal medicine journal.

[1043]  F. Gaita,et al.  Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy. , 2007, The American journal of cardiology.

[1044]  G. Lip,et al.  Educational Intervention Improves Anticoagulation Control in Atrial Fibrillation Patients: The TREAT Randomised Trial , 2013, PloS one.

[1045]  J. Messenger,et al.  Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study. , 2015, JACC. Cardiovascular interventions.

[1046]  Thomas Bodenheimer,et al.  Improving primary care for patients with chronic illness. , 2002, JAMA.

[1047]  A. Manolis,et al.  Transesophageal Overdrive Pacing: A Simple and Versatile Tool , 2013 .

[1048]  Hung-Fat Tse,et al.  Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation* , 2009, Critical care medicine.

[1049]  S. Connolly,et al.  Dabigatran versus warfarin in patients with mechanical heart valves. , 2013, The New England journal of medicine.

[1050]  Paul J. Wang,et al.  Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation. , 2012, Journal of the American College of Cardiology.

[1051]  R. Villareal,et al.  Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. , 2004, Journal of the American College of Cardiology.

[1052]  F. Martínez-Marcos,et al.  Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm. , 2000, The American journal of cardiology.

[1053]  J Clémenty,et al.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. , 1998, The New England journal of medicine.

[1054]  A. Garson,et al.  Incidence and management of dysrhythmias after Fontan procedure. , 1993, Herz.

[1055]  Helmut Pürerfellner,et al.  Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. , 2014, Journal of the American College of Cardiology.

[1056]  C. Israel,et al.  Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care. , 2004, Journal of the American College of Cardiology.

[1057]  Javier Moreno,et al.  Activation of Inward Rectifier Potassium Channels Accelerates Atrial Fibrillation in Humans: Evidence for a Reentrant Mechanism , 2006, Circulation.

[1058]  A. Laggner,et al.  Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[1059]  A. Camm,et al.  Ranolazine in the treatment of atrial fibrillation: Results of the dose-ranging RAFFAELLO (Ranolazine in Atrial Fibrillation Following An ELectricaL CardiOversion) study. , 2015, Heart rhythm.